var title_f42_29_43472="Pacemaker pocket erosion";
var content_f42_29_43472=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pacemaker pocket erosion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 259px; height: 392px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The pacemaker generator, implanted several years prior to presentation, is clearly visible beneath the skin and is on the verge of complete erosion (arrow). The patient was asymptomatic. The device and leads were easily removed. Although purulent material was present, cultures of the pocket obtained at the time of explant were negative. A new pacing system was placed on the contralateral side.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Margaret Lloyd, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43472=[""].join("\n");
var outline_f42_29_43472=null;
var title_f42_29_43473="Facial musculoskeletal asym";
var content_f42_29_43473=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F64450&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F64450&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Facial asymmetry",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 271px; height: 349px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The left side of this patient's face is smaller than the right. Temporomandibular joint dysfunction is more common in patients with facial asymmetry. Other associated features may include scoliosis and a short leg.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sheon, RP, Moskowitz, RW, Goldberg, VM. Soft Tissue Rheumatic Pain: Recognition, Management, Prevention, 3rd ed, Williams &amp; Wilkins, Baltimore 1996.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43473=[""].join("\n");
var outline_f42_29_43473=null;
var title_f42_29_43474="Melanosis coli Endosc";
var content_f42_29_43474=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F50472&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F50472&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Melanosis coli",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 368px; height: 183px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Colonoscopic views of a patient with chronic senna ingestion. The dark pigmentation with a reticulated pattern of striations (alligator-skin) and spots is characteristic of melanosis coli.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James B McGee, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal sigmoid colon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 216px; height: 216px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic appearance of the normal sigmoid colonic mucosa. The fine vasculature is easily visible, and the surface is shiny and smooth. The folds are of normal thickness.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James B McGee, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43474=[""].join("\n");
var outline_f42_29_43474=null;
var title_f42_29_43475="Tromethamine: Drug information";
var content_f42_29_43475=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tromethamine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?6/23/6515?source=see_link\">",
"    see \"Tromethamine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/5/19539?source=see_link\">",
"    see \"Tromethamine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F232038\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      THAM&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F232051\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Alkalinizing Agent, Parenteral",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F232039\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Dose depends on buffer base deficit; when deficit is known: tromethamine (mL of 0.3 M solution) = body weight (kg) x base deficit (mEq/L) x 1.1",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Metabolic acidosis with cardiac arrest:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.V.:",
"     </i>",
"     3.6-10.8 g (111-333 mL); additional amounts may be required to control acidosis after arrest reversed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Open chest: Intraventricular:",
"     </i>",
"     2-6 g (62-185 mL).",
"     <b>",
"      Note:",
"     </b>",
"     Do not inject into cardiac muscle",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acidosis associated with cardiac bypass surgery:",
"     </b>",
"     I.V.: Average dose: 9 mL/kg (2.7 mEq/kg); 500 mL is adequate for most adults; maximum dose: 500 mg/kg in &le;1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Excess acidity of acid citrate dextrose (ACD) blood in coronary artery surgery:",
"     </i>",
"     15-77 mL of 0.3 molar solution added to each 500 mL of blood",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F232046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/5/19539?source=see_link\">",
"      see \"Tromethamine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Metabolic acidosis associated with RDS:",
"     </b>",
"     I.V.: Infants: Initial: Approximately 1 mL/kg for each pH unit below 7.4; additional doses determined by changes in PaO",
"     <sub>",
"      2",
"     </sub>",
"     , pH, and pCO",
"     <sub>",
"      2",
"     </sub>",
"     ;",
"     <b>",
"      Note:",
"     </b>",
"     Although THAM&reg; solution does not raise pCO",
"     <sub>",
"      2",
"     </sub>",
"     when treating metabolic acidosis with concurrent respiratory acidosis, bicarbonate may be preferred because the osmotic effects of THAM&reg; are greater.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F232040\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F232041\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution; monitor for toxicity.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F232027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     THAM&reg;: 18 g (500 mL) [0.3 molar]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F232014\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F232030\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Maximum concentration: 0.3 molar; infuse slowly over at least 1 hour; to avoid glucose or potassium changes, should not exceed 16.5 mL/kg in 1 hour",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F232029\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Correction of metabolic acidosis associated with cardiac bypass surgery or cardiac arrest; to correct excess acidity of stored blood that is preserved with acid citrate dextrose (ACD); indicated in infants needing alkalinization after receiving maximum sodium bicarbonate (8-10 mEq/kg/24 hours)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F3123324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Tromethamine may be confused with TrophAmine&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F232049\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hypervolemia, venospasm",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyperkalemia, hypoglycemia (usually doses &gt;500 mg/kg administered over &lt;1 hour)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatic necrosis (resulted during delivery via umbilical venous catheter)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Necrosis with extravasation, phlebitis, tissue irritation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Apnea, pulmonary edema, respiratory depression",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F232033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to tromethamine or any component of the formulation; uremia or anuria; chronic respiratory acidosis (neonates); salicylate intoxication (neonates)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F232018\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypoglycemia: May cause hypoglycemia with extremely large doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory depression: May cause respiratory depression; monitor closely especially if patient not intubated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; reduce dose and monitor pH carefully.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Duration of therapy: Drug should not be given for a period of longer than 24 hours unless for a life-threatening situation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Extravasation: Avoid extravasation; may cause tissue necrosis.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6223545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Alkalinizing Agents may decrease the excretion of Amphetamines.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Flecainide: Tromethamine may increase the serum concentration of Flecainide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNINE: Alkalinizing Agents may increase the serum concentration of QuiNINE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F232023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F3341462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have not been conducted. There are no adequate and well-controlled studies in pregnant women. Use only if potential benefit outweighs possible risk to the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F3341464\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16324044\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Tham Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30 mEq/100 mL (500 mL): $264.60",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F232025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum electrolytes (especially potassium, blood glucose); renal function, arterial blood gases,  ECG monitoring, fluid status, ventilation rate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Check infusion site frequently during administration.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F232028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pH (physiologic): 7.38-7.42",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F12992801\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Addex-Tham (SE);",
"     </li>",
"     <li>",
"      Tham (DE, GR);",
"     </li>",
"     <li>",
"      Thamesol (IT)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F232017\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acts as a proton acceptor, which combines with hydrogen ions, liberating  bicarbonate buffer, to correct acidosis. It buffers both metabolic and respiratory acids, limiting carbon dioxide generation. Also an osmotic diuretic.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F232032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Distributes quickly into extracellular space; at steady state distributes into a volume slightly greater than total body water; penetrates slowly intracellularly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 5.6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (&gt;75%) within 8 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Adrogue HJ and Madias NE, &ldquo;Management of Life-Threatening Acid-Base Disorders: First of Two Parts,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1998, 338(1):26-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/29/43475/abstract-text/9414329/pubmed\" id=\"9414329\" target=\"_blank\">",
"        9414329",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brierley J, Carcillo JA, Choong K, et al, &ldquo;Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock: 2007 Update from the American College of Critical Care Medicine,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2009, 37(2):666-88.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/29/43475/abstract-text/19325359/pubmed\" id=\"19325359\" target=\"_blank\">",
"        19325359",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nahas GG, Sutin KM, Fermon C, et al, &ldquo;Guidelines for the Treatment of Acidaemia With THAM,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1998, 55(2): 191-224.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10027 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-210.101.131.232-DB21B48F7E-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43475=[""].join("\n");
var outline_f42_29_43475=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232038\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232051\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232039\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232046\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232040\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232041\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232027\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232014\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232030\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232029\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3123324\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232049\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232033\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232018\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300183\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6223545\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232023\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3341462\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3341464\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16324044\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232025\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232028\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12992801\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232017\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232032\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10027\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10027|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?6/23/6515?source=related_link\">",
"      Tromethamine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/5/19539?source=related_link\">",
"      Tromethamine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_29_43476="Pegfilgrastim: Pediatric drug information";
var content_f42_29_43476=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Pegfilgrastim: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?12/28/12741?source=see_link\">",
"    see \"Pegfilgrastim: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?31/44/32452?source=see_link\">",
"    see \"Pegfilgrastim: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F206840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Neulasta&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F855049\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Neulasta&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F2530591\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Colony Stimulating Factor",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F2530601\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?12/28/12741?source=see_link\">",
"      see \"Pegfilgrastim: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     SubQ:",
"     <b>",
"      Note:",
"     </b>",
"     Do not administer in the period between 14 days before and 24 hours after administration of cytotoxic chemotherapy. According to the NCCN guidelines, efficacy has been demonstrated with every 2-week chemotherapy regimens; however, benefit has not been demonstrated with regimens under a 2-week duration (Myeloid Growth Factor Guidelines, v.1, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children (limited studies in children): 100 mcg/kg (maximum dose: 6 mg) once per chemotherapy cycle, beginning 24-72 hours after completion of chemotherapy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adolescents &gt;45 kg and Adults: 6 mg once per chemotherapy cycle, beginning 24-72 hours after completion of chemotherapy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     No adjustment necessary",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F206826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neulasta&reg;: 6 mg/0.6 mL (0.6 mL) [contains natural rubber/natural latex in packaging]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F206813\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F2530602\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: SubQ: Administer undiluted solution; do not shake",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F2530598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store in refrigerator; do not freeze; if inadvertently frozen, allow to thaw in refrigerator; discard if frozen more than one time. Allow to reach room temperature prior to injection. May be kept at room temperature for up to 48 hours. Protect from light.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F2530592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduction of the duration of neutropenia and the associated risk of infection in patients with nonmyeloid malignancies receiving myelosuppressive chemotherapeutic regimens associated with a significant incidence of febrile neutropenia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F2839880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Neulasta&reg; may be confused with Neumega&reg;, Neupogen&reg;, Nuedexta&trade;, and Lunesta&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F206860\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Peripheral edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Constipation, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, bone pain, myalgia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Antibody formation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Acute respiratory distress syndrome (ARDS), allergic reaction, anaphylaxis, cutaneous vasculitis, erythema, fever, flushing, hyperleukocytosis, hypoxia, injection site reactions (erythema, induration, pain), leukocytosis, rash, sickle cell crisis, splenic rupture, Sweet's syndrome (acute febrile dermatosis), urticaria. Cytopenias resulting from an antibody response to exogenous growth factors have been reported on rare occasions in patients treated with other recombinant growth factors.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F2530594\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to filgrastim, pegfilgrastim, or any component; use in the period between 14 days before and 24 hours after administration of cytotoxic chemotherapy",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F5628617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in any malignancy with myeloid characteristics due to pegfilgrastim's potential to act as a growth factor; use with caution in patients with gout; psoriasis; monitor patients with pre-existing cardiac conditions as cardiac events (MIs, arrhythmias) have been reported in premarketing clinical studies with the parent drug filgrastim. The 6 mg fixed dose should not be used in infants, children, and adolescents weighing &lt;45 kg.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F2530595\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Splenic rupture, including fatal cases, has been reported following the administration of pegfilgrastim. Patients experiencing left upper abdominal and/or shoulder tip pain should be evaluated for an enlarged spleen or splenic rupture. ARDS has been reported with use; evaluate patients with pulmonary symptoms such as fever, lung infiltrates, or respiratory distress; withhold or discontinue pegfilgrastim if ARDS occurs. Allergic reactions including anaphylaxis, angioedema, skin rash, erythema, and urticaria have occurred primarily with the initial dose and may recur after discontinuation (reaction may be delayed); close follow-up for several days and permanent discontinuation are recommended for severe reactions.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Do not administer 14 days prior to or within 24 hours following the administration of chemotherapy due to the potential sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy. Benefit has not been demonstrated with regimens under a 2-week duration. Administration on the same day as chemotherapy is not recommended (NCCN Myeloid Growth Factor Guidelines, v.1, 2009). Safety and efficacy have not been evaluated for use in peripheral blood progenitor cell (PBPC) mobilization or in patients receiving radiation therapy. May precipitate sickle cell crises in patients with sickle cell disease; carefully evaluate potential risks vs benefits when considering use in this patient population. Use has not been evaluated in patients receiving chemotherapy associated with delayed myelosuppression (eg, nitrosoureas, mitomycin C).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F206820\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegloticase: May diminish the therapeutic effect of Pegfilgrastim.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F206822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F206834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have demonstrated adverse effects and fetal loss. There are no adequate and well-controlled studies in pregnant women; use only if potential benefit to mother justifies the potential risk to the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F2530603\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Temperature, CBC with differential and platelet count",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Evaluate for left upper abdominal pain, shoulder tip pain, or splenomegaly. Monitor for sickle cell crisis (in patients with sickle cell anemia).",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F2530599\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pegfilgrastim is a covalent conjugate of filgrastim and monomethoxypolyethylene glycol. It stimulates the production, maturation, and activation of neutrophils to increase both their migration and cytotoxicity. Pegfilgrastim has reduced renal clearance and prolonged persistence",
"     <i>",
"      in vivo",
"     </i>",
"     when compared with filgrastim.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F2530600\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Half-life: Adults: 15-80 hours; Children (100 mcg/kg dose): ~20-30 hours (range: Up to 68 hours)",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Elimination: Primarily through binding to neutrophils",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F2530604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?31/44/32452?source=see_link\">",
"      see \"Pegfilgrastim: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Possible bone pain; notify physician of unusual fever or chills, severe bone pain, or chest pain and palpitations",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Andr&eacute; N, Kababri ME, Bertrand P, et al, \"Safety and Efficacy of Pegfilgrastim in Children With Cancer Receiving Myelosuppressive Chemotherapy,\"",
"      <i>",
"       Anticancer Drugs",
"      </i>",
"      , 2007, 18(3):277-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/29/43476/abstract-text/17264759/pubmed\" id=\"17264759\" target=\"_blank\">",
"        17264759",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Andr&eacute; N, Milano E, Rome A, et al, \"Safety of Pegfilgrastim in Children,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2008, 42(2):290.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/29/43476/abstract-text/18182474/pubmed\" id=\"18182474\" target=\"_blank\">",
"        18182474",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fox E, Jayaprakash N, Widemann BC, et al, &ldquo;Randomized Trial and Pharmacokinetic Study of Pegfilgrastim vs. Filgrastim in Children and Young Adults With Newly Diagnosed Sarcoma Treated With Dose Intensive Chemotherapy,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2006, 24(18S):9020 [abstract from 2006 ASCO Annual Meeting Proceedings, Part I].",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Koontz SE, Mohassel LR, Jaffe N, et al, &ldquo;Safety and Efficacy of Pegfilgrastim in Pediatric Oncology Patients: The M.D. Anderson Cancer Center Experience,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2004, 22(14S):8272.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Comprehensive Cancer Network (NCCN), &ldquo;Clinical Practice Guidelines in Oncology&trade;: Myeloid Growth Factors,&rdquo; Version 1, 2009. Available at file://www.nccn.org/professionals/physician_gls/PDF/myeloid_growth.pdf.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith TJ, Khatcheressian J, Lyman GH, et al, \"2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline,\"",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2006, 24(19):3187-205.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/29/43476/abstract-text/16682719/pubmed\" id=\"16682719\" target=\"_blank\">",
"        16682719",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Snyder RL and Stringham DJ, &ldquo;Pegfilgrastim-Induced Hyperleukocytosis,&rdquo;",
"      <i>",
"       Ann of Pharmacother",
"      </i>",
"      , 2007, 41(9):1524-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/29/43476/abstract-text/16282899/pubmed\" id=\"16282899\" target=\"_blank\">",
"        16282899",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      te Poele EM, Kamps WA, Tamminga, RY, et al, &ldquo;Pegfilgrastim in Pediatric Cancer Patients,&rdquo;",
"      <i>",
"       J Pediat Hematol Oncol",
"      </i>",
"      , 2005, 27(11):627-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/29/43476/abstract-text/16282899/pubmed\" id=\"16282899\" target=\"_blank\">",
"        16282899",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wendelin G, Lackner H, Schwinger W, et al, &ldquo;Once-Per-Cycle Pegfilgrastim Versus Daily Filgrastim in Pediatric Patients With Ewing Sarcoma,&rdquo;",
"      <i>",
"       J Pediatr Hematol Oncol",
"      </i>",
"      , 2005, 27(8):449-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/29/43476/abstract-text/16096530/pubmed\" id=\"16096530\" target=\"_blank\">",
"        16096530",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13067 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-704953041C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43476=[""].join("\n");
var outline_f42_29_43476=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206840\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F855049\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530591\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530601\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206826\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206813\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530602\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530598\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530592\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2839880\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206860\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530594\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5628617\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530595\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299830\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206820\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206822\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206834\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530603\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530599\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530600\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530604\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13067\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13067|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?12/28/12741?source=related_link\">",
"      Pegfilgrastim: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?31/44/32452?source=related_link\">",
"      Pegfilgrastim: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_29_43477="Alendronate: Patient drug information";
var content_f42_29_43477=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Alendronate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/10/24743?source=see_link\">",
"     see \"Alendronate: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F131404\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Binosto&trade;;",
"     </li>",
"     <li>",
"      Fosamax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F131405\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Alendronate-FC;",
"     </li>",
"     <li>",
"      Apo-Alendronate&reg;;",
"     </li>",
"     <li>",
"      CO Alendronate;",
"     </li>",
"     <li>",
"      Dom-Alendronate;",
"     </li>",
"     <li>",
"      Fosamax&reg;;",
"     </li>",
"     <li>",
"      JAMP-Alendronate;",
"     </li>",
"     <li>",
"      Mylan-Alendronate;",
"     </li>",
"     <li>",
"      PHL-Alendronate;",
"     </li>",
"     <li>",
"      PMS-Alendronate;",
"     </li>",
"     <li>",
"      PMS-Alendronate-FC;",
"     </li>",
"     <li>",
"      Q-Alendronate;",
"     </li>",
"     <li>",
"      ratio-Alendronate;",
"     </li>",
"     <li>",
"      Riva-Alendronate;",
"     </li>",
"     <li>",
"      Sandoz-Alendronate;",
"     </li>",
"     <li>",
"      Teva-Alendronate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F11440675\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025045\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691525",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put off or treat soft, brittle bones (osteoporosis).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Paget's disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025044\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to alendronate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: A swallowing tube (esophagus) that is not normal, low calcium levels, or trouble swallowing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701337",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to stand or sit up for 30 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025049\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697223",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have GI (gastrointestinal) disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are on a low-salt diet (this drug has salt), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have a bone density test. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025050\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain or heartburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698211",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low calcium levels.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697918",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bone, joint, or muscle pain may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2927622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A broken leg may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698193",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the jaw bone may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025052\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad jaw pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698644",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble swallowing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699013",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bone, joint, or muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2927623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad groin or thigh pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698986",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your mouth.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699099",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Twitching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025047\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695883",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach before breakfast.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695897",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water at least 30 minutes before the first food, drink, or drugs of the day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694729",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not lie down for at least 30 minutes after taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696101",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug works best when used with calcium/vitamin D and weight-bearing workouts like walking or PT (physical therapy).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Tablet:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695915",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with plain water only. Avoid taking with mineral water or other drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3911433",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Effervescent tablets:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694661",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Melt the effervescent tablet in",
"       <sup>",
"        1",
"       </sup>",
"       /",
"       <sub>",
"        2",
"       </sub>",
"       cup of water. Do not swallow the tablet whole.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3911882",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       When the water stops bubbling, wait at least 5 more minutes then stir for about 10 seconds and drink.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025048\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025053\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3911433",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Effervescent tablets:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store tablets in the original container at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025054\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12489 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-16712FB15A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43477=[""].join("\n");
var outline_f42_29_43477=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131404\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131405\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11440675\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025045\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025044\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025049\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025050\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025052\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025047\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025048\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025053\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025054\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?24/10/24743?source=related_link\">",
"      Alendronate: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_29_43478="Annular elastolytic giant cell granuloma - arm";
var content_f42_29_43478=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F51388%7EDERM%2F65166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F51388%7EDERM%2F65166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Annular elastolytic giant cell granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 325px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Annular erythematous patches and plaques are present on sun-exposed skin. A biopsy revealed findings consistent with annular elastolytic giant cell granuloma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Benjamin Ehst, MD, PhD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Annular elastolytic giant cell granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mulitiple annular erythematous patches and plaques were present on the neck and arms. A biopsy revealed findings consistent with annular elastolytic giant cell granuloma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Benjamin Ehst, MD, PhD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43478=[""].join("\n");
var outline_f42_29_43478=null;
var title_f42_29_43479="Evaluation of dysuria in children";
var content_f42_29_43479=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of dysuria in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/29/43479/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/29/43479/contributors\">",
"     Gary R Fleisher, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/29/43479/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/29/43479/contributors\">",
"     Stephen J Teach, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/29/43479/contributors\">",
"     Teresa K Duryea, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/29/43479/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/29/43479/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/29/43479/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many conditions of the genitourinary tract cause dysuria, which is defined as symptoms of pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    burning associated with urination. This commonly reported sensation is produced by the muscular contraction of the bladder and the peristaltic activity of the urethra, both of which stimulate the pain fibers of the edematous and inflamed mucosa.",
"   </p>",
"   <p>",
"    Young children may also complain of painful urination when they are instead experiencing related symptoms, such as pruritus as is seen with Enterobius vermicularis (pinworms). In addition, those who have experienced sexual abuse may present with a complaint of dysuria, which has no physical basis, or they may exhibit behaviors that are interpreted by adult observers as indicative of genital pain.",
"   </p>",
"   <p>",
"    This topic will review the causes of dysuria and the approach to the child with dysuria. The evaluation of adult women with dysuria, the features and diagnosis of urinary tract infections in children, and the evaluation of sexual abuse in children and adolescents are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13561?source=see_link\">",
"     \"Acute uncomplicated cystitis and pyelonephritis in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/27/35258?source=see_link\">",
"     \"Evaluation of sexual abuse in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysuria may be caused by a wide range of infectious and noninfectious causes, but it usually stems from one of several common disorders of childhood and adolescence (",
"    <a class=\"graphic graphic_table graphicRef55819 \" href=\"mobipreview.htm?32/59/33724\">",
"     table 1",
"    </a>",
"    ). Most children with dysuria as a chief complaint will have primary disorders of the genitourinary tract. Although patients with urethritis secondary to systemic illnesses may have dysuria as one of their many symptoms, this specific complaint is only occasionally the principal reason for seeking care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Life-threatening conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stevens-Johnson syndrome is a severe manifestation of erythema multiforme, which may affect the mucous membranes throughout the body; this produces conjunctivitis, oral ulceration, and urethritis. The rash that occurs most often has the appearance of target lesions. Although usually self-limited, pulmonary involvement may lead to death. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Common conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most children with dysuria have an infection of the genitourinary tract, noninfectious processes that irritate periurethral tissue also cause dysuria relatively often.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Infectious causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infections of the genitourinary tract and perineum, and less commonly systemic infections, can cause dysuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pyelonephritis &ndash; Pyelonephritis, defined as infection of the upper genitourinary tract, is the most serious infection of the genitourinary tract among nonsexually active children and adolescents. It usually manifests with fever, frequently above 38.5 to 39&ordm;C, and flank pain or tenderness (older children and adolescents). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lower urinary tract infections &ndash; Patients with cystitis or lower urinary tract infection (UTI) often present with suprapubic pain or tenderness. They may or may not have fever, which, if present, is usually low grade. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/59/42937?source=see_link\">",
"       \"Acute cystitis in children older than two years and adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urethritis &ndash; Urethritis is a more localized infection that commonly produces a discharge. In adolescents, Neisseria gonorrhoeae and Chlamydia trachomatis are the most commonly isolated pathogens [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/4\">",
"       4",
"      </a>",
"      ]. When herpes simplex (HSV) causes urethritis, vesicles",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ulcers are usually apparent on examination [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/5\">",
"       5",
"      </a>",
"      ]. Note that HSV in prepubertal children may occur from autoinoculation in conjunction with herpetic stomatis or may result from sexual contact.(See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/51/37689?source=see_link&amp;anchor=H11#H11\">",
"       \"Sexually transmitted diseases: Overview of issues specific to adolescents\", section on 'STD clinical patterns'",
"      </a>",
"      .) A sexually transmitted etiology in prepubertal children should raise concern for sexual abuse. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/27/35258?source=see_link\">",
"       \"Evaluation of sexual abuse in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bulbar urethritis &ndash; Bulbar urethritis, a urological problem that affects adolescent males, presents with dysuria and microscopic hematuria. It is presumably of viral origin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Balanitis and balanoposthitis &ndash; Younger boys may develop a nonspecific bacterial infection of the distal penis with involvement of the glans penis (balanitis) or, if uncircumcised, both the glans and the prepuce (balanoposthitis). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/23/24953?source=see_link\">",
"       \"Balanoposthitis in children: Clinical manifestations, diagnosis, and treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vaginitis &ndash; Vaginitis may cause dysuria in both prepubertal girls and adolescents [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. Sexually transmitted pathogens and Candida albicans are frequently isolated in postpubertal girls. Although these same organisms may be found in younger girls, one must consider nonsexually transmitted agents, such as Group A Streptococcus and Shigella species. In many cases, the physical examination reveals a discharge, which varies from scant (nonspecific vaginitis) to thick and green (gonorrhea), to white and cheesy (Candida). Foreign bodies may also be a cause of vaginitis leading to dysuria in prepubertal girls. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/29/26072?source=see_link\">",
"       \"Vulvovaginal complaints in the prepubertal child\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/51/37689?source=see_link&amp;anchor=H11#H11\">",
"       \"Sexually transmitted diseases: Overview of issues specific to adolescents\", section on 'STD clinical patterns'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cervicitis &ndash; In the setting of a clinic for sexually transmitted diseases (STDs), infectious urethritis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cervicitis was the source of isolated dysuria in up to 30 percent of adolescent girls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pelvic inflammatory disease &ndash; Asymptomatic infections of the lower genitourinary tract by Neisseria gonorrhoeae and Chlamydia trachomatis may lead to the development of pelvic inflammatory disease (PID) in postpubertal females, which can have serious consequences if left untreated. Although PID may be accompanied by dysuria, fever and",
"      <span class=\"nowrap\">",
"       abdominal/pelvic",
"      </span>",
"      pain are usually the chief complaints. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Varicella &ndash; Varicella usually begins with a febrile prodrome. After two to three days, a characteristic pruritic rash appears centrally and then spreads peripherally. By the second or third day of the eruption, lesions may involve the perineum and vagina and lead to a complaint of itching",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      dysuria. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33480?source=see_link\">",
"       \"Clinical features of varicella-zoster virus infection: Chickenpox\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Noninfectious conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Irritation around the urethra from any source can cause dysuria.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chemical urethritis &ndash; Potential local irritants include detergents, fabric softeners, perfumed soaps, and possibly bubble baths. Patients may have either no physical findings or only mild erythema, but they generally do not develop a discharge.",
"     </li>",
"     <li>",
"      Trauma &ndash; Minor injury is another relatively common cause of urethral irritation. In both older children and adolescents, normal self-exploratory sexual play, masturbation, voluntary sexual activity, or sexual abuse may be the source of the trauma. As in patients with chemical urethritis, the examination is generally unremarkable.",
"     </li>",
"     <li>",
"      Labial adhesions &ndash; Labial adhesions occur relatively often in young girls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/10\">",
"       10",
"      </a>",
"      ]. Although they are most frequently asymptomatic, microtears may occasionally cause dysuria. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/29/26072?source=see_link&amp;anchor=H23#H23\">",
"       \"Vulvovaginal complaints in the prepubertal child\", section on 'Labial adhesions'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Other conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of other conditions may uncommonly cause dysuria in children.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Urinary stones &ndash; Urinary stones develop occasionally in children and adolescents, usually in the setting of anatomic abnormalities",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      recurrent infection. Their passage may be associated with complaint of dysuria, but usually with flank pain and hematuria. Children with idiopathic hypercalciuria and idiopathic hyperuricosuria, known antecedents of renal calculi, may complain of dysuria even in the absence of an observable stone and may also have hematuria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/11-14\">",
"       11-14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Urethral strictures &ndash; Urethral strictures, both congenital and acquired, may present with signs of obstruction such as urinary retention, as well as dysuria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dysfunctional elimination &ndash; Dysfunctional elimination is a condition that may mimic UTI or urethritis, but it does not usually present acutely. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26360?source=see_link&amp;anchor=H8#H8\">",
"       \"Epidemiology and risk factors for urinary tract infections in children\", section on 'Host factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lichen sclerosis &ndash; Lichen sclerosis or lichen sclerosis et atrophicus, which affects primarily older women, occurs occasionally in prepubertal females [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/15,16\">",
"       15,16",
"      </a>",
"      ]. Affected girls most often seek care for a perineal rash, but they may complain of pruritus. The appearance of lichen sclerosis, which consists of a depigmentation around the vagina and anus in the shape of an hourglass, is usually diagnostic (",
"      <a class=\"graphic graphic_picture graphicRef55275 \" href=\"mobipreview.htm?6/33/6687\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/45/6874?source=see_link\">",
"       \"Vulvar lichen sclerosus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/29/26072?source=see_link\">",
"       \"Vulvovaginal complaints in the prepubertal child\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Virginal vaginal ulcers &ndash; Virginal vaginal (Lipschutz) ulcers is an unusual idiopathic condition that principally affects prepubertal females [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/17\">",
"       17",
"      </a>",
"      ]. The characteristic clustered vesicles resemble herpes simplex, which must be ruled out definitively by culture to obviate concerns of sexual abuse. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/29/26072?source=see_link&amp;anchor=H16#H16\">",
"       \"Vulvovaginal complaints in the prepubertal child\", section on 'Vulvar ulcers'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Conjunctivitis, arthritis, and urethritis &ndash; Reactive arthritis is a form of juvenile spondyloarthritis that is more common in males; it may be accompanied by conjunctivitis and urethritis. It is rarely seen in children. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/27/33210?source=see_link\">",
"       \"Reactive arthritis (formerly Reiter syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Beh&ccedil;et's syndrome &ndash; Beh&ccedil;et's syndrome is a rare multisystem disease characterized by recurrent oral ulcerations, ocular panuveitis, vasculitis and, less commonly, genital ulcerations that may produce dysuria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/18\">",
"       18",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/18/298?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Beh&ccedil;et&rsquo;s disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Psychogenic &ndash; Throughout childhood and into adolescence, a complaint of dysuria may be psychogenic in origin, occurring in the absence of inflammation in the genitourinary tract.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important historic questions relate to the presence of symptoms outside of the genitourinary tract, fever, local exposures, trauma, and sexual activity.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptoms outside of the genitourinary tract &ndash; A history of conjunctival erythema, oral lesions, joint pain or swelling,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a generalized rash suggests systemic inflammatory or infectious conditions, such as Stevens-Johnson syndrome, reactive arthritis, Beh&ccedil;et's syndrome, or varicella. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link\">",
"       \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Fever &ndash; Fever points to infections, such as varicella, pyelonephritis, or pelvic inflammatory disease, none of which is likely to present with dysuria alone.",
"     </li>",
"     <li>",
"      Local exposures and trauma &ndash; Both local trauma and exposure to chemicals, such as detergents, fabric softeners, perfumed soaps, and bubble baths, may irritate the mucosal lining of the urethra or bladder. A negative history for injury may not be accurate, however, because most trauma is not recalled by young patients, or in the case of masturbation or abuse, may be denied.",
"     </li>",
"     <li>",
"      Sexual activity &ndash; The detection of STDs, a common cause of dysuria in adolescents, will be facilitated by obtaining a history about the nature and extent of sexual activity; however, a denial of sexual activity does not exclude this possibility.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific findings on physical examination may suggest a particular underlying cause of dysuria:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fever &ndash; Fever may occur with any infection, particularly varicella, urinary tract infection (especially pyelonephritis), and pelvic inflammatory disease.",
"     </li>",
"     <li>",
"      Extra-genital findings &ndash; A generalized rash may suggest either Stevens-Johnson syndrome (target lesions) or varicella (vesicles). Ocular involvement, manifesting as conjunctival inflammation, occurs with both Stevens-Johnson and Beh&ccedil;et's syndrome. Arthritis in association with urethritis and conjunctivitis is present in some children with reactive arthritis (formerly Reiter syndrome). Oral ulcers are seen in both Stevens-Johnson and Beh&ccedil;et's syndromes as well as with herpes stomatitis leading to autoinoculation of the genital tract. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33480?source=see_link\">",
"       \"Clinical features of varicella-zoster virus infection: Chickenpox\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Genital findings &ndash; Findings to note in the genital area include depigmentation (lichen sclerosis), adhesion of the labia, vesicles",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ulcerations, and a discharge. Ulcerated",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vesicular lesions occur most often with herpes simplex but may also be seen with systemic diseases (Stevens-Johnson, Beh&ccedil;et's syndrome, varicella) or be the presentation of idiopathic virginal vaginal ulcers.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A discharge accompanies a variety of vaginal and urethral infections. The character of a discharge may suggest a specific pathogen: scant (nonspecific or chlamydial vaginitis or chlamydial urethritis in the male), cheesy (candidal vaginitis), green (gonorrhea in either the male of female), or bloody (Group A streptococcus or Shigella in the prepubertal female).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     LABORATORY STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ancillary testing should always be guided by the history and physical examination. Microbiologic testing of urethral, cervical, or vaginal discharge may be diagnostic. Testing of urine is usually indicated when evaluating a complaint of dysuria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Gram stain",
"    </span>",
"    &nbsp;&mdash;&nbsp;A Gram stain of urethral or vaginal discharge may be helpful. In prepubertal girls or boys of any age, the finding of gram-negative intracellular diplococci suggests the diagnosis of gonorrhea. For this reason, we recommend performing a Gram stain in the prepubertal child with urethral or vaginal discharge. The identification of gram-negative diplococci in this age group warrants evaluation for sexual abuse. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/27/35258?source=see_link\">",
"     \"Evaluation of sexual abuse in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By comparison, nonpathogenic organisms that colonize the vagina after puberty have the same appearance as N. gonorrhoeae on Gram stain. As a result, this test on urethral or vaginal discharge is unreliable in teenage girls.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Urine testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A urinalysis and urine culture should be obtained when the diagnosis is not obvious based upon the history and physical examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Specimens for culture should be collected by catheter or suprapubic aspiration in diapered children. Clean catch specimens may be analyzed in those who are toilet-trained. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/56/42886?source=see_link\">",
"     \"Urine collection techniques in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In prepubertal children, a positive dipstick result, pyuria (more than 5 to 10 white blood cells per high-power field in spun urine), or enhanced urinalysis with &ge;10",
"    <span class=\"nowrap\">",
"     WBC/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    on urinalysis increases the likelihood of bacterial infection (urethritis, cystitis, or pyelonephritis), but the diagnosis must be confirmed by culture. (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Rapidly available tests'",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    Pyuria may also be observed in inflammatory conditions, such as chemical urethritis, and nonbacterial infections. Conversely, urinary tract infections may occasionally occur in children in the absence of pyuria on routine urinalysis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'False negatives'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link&amp;anchor=H23#H23\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Other considerations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Other cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;As many as 10 percent of infants under one year of age with urinary tract infections (UTIs) who are highly febrile (&gt;39&ordm;C) may be bacteremic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/21\">",
"     21",
"    </a>",
"    ]. There is limited evidence suggesting that similar outcomes occur among young children with bacteremic UTIs and those with non-bacteremic UTIs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/22\">",
"     22",
"    </a>",
"    ]. Nevertheless, it is our practice to obtain a blood culture in infants &le;6 months of age with UTIs who have fever &gt;39&ordm;C.",
"   </p>",
"   <p>",
"    Additional studies are indicated when sexually transmitted diseases are suspected based either on a history of exposure or the finding of discharge",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    genital lesions. A culture may be used to diagnose a variety of organisms, such as gonorrhea and Chlamydia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/27/35258?source=see_link\">",
"     \"Evaluation of sexual abuse in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Nucleic acid amplification tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urine can be tested for the presence of C. trachomatis and N. gonorrhoeae using nucleic acid amplification tests (NAATs). These tests offer an accurate screening tool for sexually transmitted diseases (STDs) without performing a culture of the cervix or, in the male, of the urethra. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/51/37689?source=see_link&amp;anchor=H16#H16\">",
"     \"Sexually transmitted diseases: Overview of issues specific to adolescents\", section on 'Screening and diagnostic testing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Direct fluorescent antibody and viral culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;For herpes simplex, a scraping for direct fluorescent antibody (DFA) testing provides a relatively rapid result, but culture is more definitive. We recommend performing both DFA testing and viral culture in prepubertal children and either test in adolescents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Pregnancy testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;In menstruating females, a urine test for pregnancy should be performed, as several of the conditions causing dysuria occur more frequently in sexually active",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    gravid women. In addition, pregnancy may influence the subsequent therapeutic choices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ALGORITHMIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial consideration should be given to serious systemic syndromes that can cause dysuria. Subsequent evaluation will be determined by the age and gender of the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Systemic syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since one important task is to recognize the rare but serious systemic syndromes, the evaluation begins with a search for a generalized process (",
"    <a class=\"graphic graphic_algorithm graphicRef60818 \" href=\"mobipreview.htm?32/15/33021\">",
"     algorithm 1",
"    </a>",
"    ). In patients with conjunctival inflammation, oral ulcers, joint findings, or a generalized rash, likely etiologies include Stevens-Johnson syndrome, Beh&ccedil;et's syndrome, reactive arthritis, and varicella.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Prepubertal male",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysuria in the prepubertal male is most often caused by an infection of the urinary tract or irritation of the urethra (",
"    <a class=\"graphic graphic_algorithm graphicRef80646 \" href=\"mobipreview.htm?25/18/25903\">",
"     algorithm 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The evaluation begins with a careful inspection of the genitalia for lesions or a discharge. Herpes simplex (HSV) and gonorrhea are unusual causes and, if present, should prompt consideration of sexual abuse. However, HSV is well described as a result of autoinoculation, particularly in boys with active herpetic stomatitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/24\">",
"       24",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/27/35258?source=see_link&amp;anchor=H5#H5\">",
"       \"Evaluation of sexual abuse in children and adolescents\", section on 'Evaluation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/27/35258?source=see_link&amp;anchor=H19#H19\">",
"       \"Evaluation of sexual abuse in children and adolescents\", section on 'Interpretation of findings'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Fever suggests urinary tract infection and, even in the absence of pyuria, merits a culture of the urine, unless an alternative diagnosis is established.",
"     </li>",
"     <li>",
"      Pyuria most often occurs in the presence of a bacterial urinary tract infection, but it may also be seen with viral cystitis.",
"     </li>",
"     <li>",
"      Many prepubertal boys will be afebrile, lack any systemic or local findings, and have a negative urinalysis. In these patients, the most likely cause is nonspecific urethritis, perhaps due to chemical exposures, or local trauma, as occurs with masturbatory play.",
"     </li>",
"     <li>",
"      Further work-up for less common conditions, such as strictures, hypercalciuria, and chlamydial urethritis, should be considered in those with persistent unexplained dysuria.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Prepubertal female",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the prepubertal female, common causes of dysuria include infections of the urinary tract and nonspecific vaginitis (",
"    <a class=\"graphic graphic_algorithm graphicRef69182 \" href=\"mobipreview.htm?0/55/895\">",
"     algorithm 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Depigmentation in the perivaginal and perianal area points to lichen sclerosis.",
"     </li>",
"     <li>",
"      Vesicles and ulceration usually indicate herpes simplex but may represent virginal vaginal ulcers or, rarely, be an early manifestation of a systemic disease. Although genital herpes in the prepubertal female may occur secondary to autoinoculation, this diagnosis warrants the investigation of the possibility of sexual abuse. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/27/35258?source=see_link&amp;anchor=H5#H5\">",
"       \"Evaluation of sexual abuse in children and adolescents\", section on 'Evaluation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/27/35258?source=see_link&amp;anchor=H19#H19\">",
"       \"Evaluation of sexual abuse in children and adolescents\", section on 'Interpretation of findings'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Labial adhesions are almost always asymptomatic, but they may sustain microtrauma and serve as a source of dysuria.",
"     </li>",
"     <li>",
"      A vaginal discharge occurs with vaginitis caused by several different pathogens, including Neisseria gonorrhoeae and C. albicans in particular.",
"     </li>",
"     <li>",
"      In the febrile girl, infection of the urinary tract is highly likely and should be pursued with a urinalysis and urine culture. Pyuria in the absence of fever usually represents a bacterial or viral cystitis.",
"     </li>",
"     <li>",
"      Patients without fever, systemic or local findings, or pyuria, are likely to have either a relatively quiescent lower urinary tract infection or nonspecific vaginitis. Further evaluation at this stage should be limited to a urine culture, unless the dysuria persists.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Adolescent male",
"    </span>",
"    &nbsp;&mdash;&nbsp;The adolescent male with dysuria is likely to have either a urinary tract infection or a sexually transmitted disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/25\">",
"     25",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_algorithm graphicRef57308 \" href=\"mobipreview.htm?22/46/23278\">",
"     algorithm 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Genital",
"      <span class=\"nowrap\">",
"       ulcers/vesicles",
"      </span>",
"      point to herpes simplex, and a discharge suggests either a gonococcal or chlamydial infection.",
"     </li>",
"     <li>",
"      Fever occurs predominantly with infections of the urinary tract. Pyuria in the absence of fever most often represents a mild cystitis or chlamydial urethritis and merits both a urine culture and testing for sexually transmitted diseases.",
"     </li>",
"     <li>",
"      In the adolescent male who has no findings on examination and no pyuria, frequent masturbation should be considered as a cause for dysuria. Further work-up is necessary only with persistent symptoms and negative cultures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Adolescent female",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common etiologies for dysuria in the adolescent female include urinary tract infections and sexually transmitted diseases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/8,25,26\">",
"     8,25,26",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_algorithm graphicRef78356 \" href=\"mobipreview.htm?24/63/25598\">",
"     algorithm 5",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Genital ulcers and vesicles are almost always caused by herpes simplex.",
"     </li>",
"     <li>",
"      Likely causes of a vaginal discharge include urethritis, cervicitis, vaginitis, and pelvic inflammatory disease (PID) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43479/abstract/8\">",
"       8",
"      </a>",
"      ]. Of these, PID is the most serious, but it infrequently causes isolated dysuria, without fever",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pelvic and abdominal pain. Pathogens that involve the lower genital tract include the sexually transmitted agents and C. albicans (",
"      <a class=\"graphic graphic_table graphicRef55819 \" href=\"mobipreview.htm?32/59/33724\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Fever points to a urinary tract infection, which may arise from either the bladder or the kidneys.",
"     </li>",
"     <li>",
"      Pyuria in the absence of fever most likely indicates relatively mild cystitis, urethritis, or cervicitis. A urine culture and testing for sexually transmitted diseases and pregnancy are indicated.",
"     </li>",
"     <li>",
"      Further evaluation in the well-appearing teenager should be undertaken only for persistent symptoms in the face of negative results from the laboratory.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many conditions of the genitourinary tract cause dysuria, which is defined as symptoms of pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    burning associated with urination. Dysuria may be caused by a wide range of infectious and noninfectious causes, but it usually stems from one of several common disorders of childhood and adolescence (",
"    <a class=\"graphic graphic_table graphicRef55819 \" href=\"mobipreview.htm?32/59/33724\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A thorough history and physical exam should be performed on all children, with attention to the presence of systemic signs, such as fever, conjunctivitis, rash and arthritis, genital lesions and discharge, local exposures, trauma, and, in adolescents, sexual activity. Children who do not have an obvious etiology for dysuria on history and physical examination should have a urine sample sent for urinalysis and culture.",
"   </p>",
"   <p>",
"    An algorithmic approach to the child with dysuria, based upon age and gender, is recommended:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Systemic syndromes (",
"      <a class=\"graphic graphic_algorithm graphicRef60818 \" href=\"mobipreview.htm?32/15/33021\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Systemic syndromes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prepubertal male (",
"      <a class=\"graphic graphic_algorithm graphicRef80646 \" href=\"mobipreview.htm?25/18/25903\">",
"       algorithm 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Prepubertal male'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prepubertal female (",
"      <a class=\"graphic graphic_algorithm graphicRef69182 \" href=\"mobipreview.htm?0/55/895\">",
"       algorithm 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Prepubertal female'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adolescent male (",
"      <a class=\"graphic graphic_algorithm graphicRef57308 \" href=\"mobipreview.htm?22/46/23278\">",
"       algorithm 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Adolescent male'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adolescent female (",
"      <a class=\"graphic graphic_algorithm graphicRef78356 \" href=\"mobipreview.htm?24/63/25598\">",
"       algorithm 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Adolescent female'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/1\">",
"      Chon CH, Lai FC, Shortliffe LM. Pediatric urinary tract infections. Pediatr Clin North Am 2001; 48:1441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/2\">",
"      Schlager TA. Urinary tract infections in infants and children. Infect Dis Clin North Am 2003; 17:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/3\">",
"      Shaw KN, Gorelick M, McGowan KL, et al. Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics 1998; 102:e16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/4\">",
"      Best D, Ford CA, Miller WC. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in pediatric private practice. Pediatrics 2001; 108:E103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/5\">",
"      Kaplan KM, Fleisher GR, Paradise JE, Friedman HN. Social relevance of genital herpes simplex in children. Am J Dis Child 1984; 138:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/6\">",
"      Farhat W, McLorie G. Urethral syndromes in children. Pediatr Rev 2001; 22:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/7\">",
"      Paradise JE, Campos JM, Friedman HM, Frishmuth G. Vulvovaginitis in premenarcheal girls: clinical features and diagnostic evaluation. Pediatrics 1982; 70:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/8\">",
"      Demetriou E, Emans SJ, Masland RP Jr. Dysuria in adolescent girls: urinary tract infection or vaginitis? Pediatrics 1982; 70:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/9\">",
"      Brunham RC, Paavonen J, Stevens CE, et al. Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med 1984; 311:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/10\">",
"      Baker RB. Dysuria: presenting complaint in labial fusion. Am J Dis Child 1986; 140:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/11\">",
"      Alon U, Warady BA, Hellerstein S. Hypercalciuria in the frequency-dysuria syndrome of childhood. J Pediatr 1990; 116:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/12\">",
"      La Manna A, Polito C, Marte A, et al. Hyperuricosuria in children: clinical presentation and natural history. Pediatrics 2001; 107:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/13\">",
"      Fallahzadeh MK, Fallahzadeh MH, Mowla A, Derakhshan A. Hypercalciuria in children with urinary tract symptoms. Saudi J Kidney Dis Transpl 2010; 21:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/14\">",
"      Parekh DJ, Pope JC IV, Adams MC, Brock JW 3rd. The role of hypercalciuria in a subgroup of dysfunctional voiding syndromes of childhood. J Urol 2000; 164:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/15\">",
"      Flynt J, Gallup DG. Childhood lichen sclerosus. Obstet Gynecol 1979; 53:79S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/16\">",
"      Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353:1777.",
"     </a>",
"    </li>",
"    <li>",
"     Lipschutz, B. Ulcus vulvae acutum. Dermat Studien 25, 1923 (quoted in Huffamn, JW. The Gynecology of Childhood and Adolescence. WB Saunders, 1988, Philadelphia, PA, pp 124-125.).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/18\">",
"      Yazici H. Beh&ccedil;et's syndrome: where do we stand? Am J Med 2002; 112:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/19\">",
"      Hoberman A, Wald ER, Reynolds EA, et al. Is urine culture necessary to rule out urinary tract infection in young febrile children? Pediatr Infect Dis J 1996; 15:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/20\">",
"      Komaroff AL. Urinalysis and urine culture in women with dysuria. Ann Intern Med 1986; 104:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/21\">",
"      Bachur R, Caputo GL. Bacteremia and meningitis among infants with urinary tract infections. Pediatr Emerg Care 1995; 11:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/22\">",
"      Honkinen O, Jahnukainen T, Mertsola J, et al. Bacteremic urinary tract infection in children. Pediatr Infect Dis J 2000; 19:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/23\">",
"      Glanz K, Saraiya M, Wechsler H, Centers for Disease Control and Prevention. Guidelines for school programs to prevent skin cancer. MMWR Recomm Rep 2002; 51:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/24\">",
"      Taieb A, Body S, Astar I, et al. Clinical epidemiology of symptomatic primary herpetic infection in children. A study of 50 cases. Acta Paediatr Scand 1987; 76:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/25\">",
"      Bremnor JD, Sadovsky R. Evaluation of dysuria in adults. Am Fam Physician 2002; 65:1589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43479/abstract/26\">",
"      Stamm WE, Counts GW, Running KR, et al. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982; 307:463.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6453 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-6A12EA632A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43479=[""].join("\n");
var outline_f42_29_43479=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CAUSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Life-threatening conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Common conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Infectious causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Noninfectious conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Other conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      LABORATORY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Gram stain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Urine testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Other cultures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Nucleic acid amplification tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Direct fluorescent antibody and viral culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Pregnancy testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ALGORITHMIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Systemic syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Prepubertal male",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Prepubertal female",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Adolescent male",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Adolescent female",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6453\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6453|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?32/15/33021\" title=\"algorithm 1\">",
"      Approach to dysuria in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?25/18/25903\" title=\"algorithm 2\">",
"      Dysuria prepubertal male",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?0/55/895\" title=\"algorithm 3\">",
"      Dysuria prepubertal female",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?22/46/23278\" title=\"algorithm 4\">",
"      Dysuria adolescent male",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?24/63/25598\" title=\"algorithm 5\">",
"      Dysuria adolescent female",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6453|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/33/6687\" title=\"picture 1\">",
"      Lichen sclerosus child",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6453|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/59/33724\" title=\"table 1\">",
"      Etiology dysuria in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/59/42937?source=related_link\">",
"      Acute cystitis in children older than two years and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13561?source=related_link\">",
"      Acute uncomplicated cystitis and pyelonephritis in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/23/24953?source=related_link\">",
"      Balanoposthitis in children: Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=related_link\">",
"      Clinical features and diagnosis of urinary tract infections in infants and children older than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33480?source=related_link\">",
"      Clinical features of varicella-zoster virus infection: Chickenpox",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/18/298?source=related_link\">",
"      Clinical manifestations and diagnosis of Beh&ccedil;et&rsquo;s disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26360?source=related_link\">",
"      Epidemiology and risk factors for urinary tract infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/27/35258?source=related_link\">",
"      Evaluation of sexual abuse in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/27/33210?source=related_link\">",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/51/37689?source=related_link\">",
"      Sexually transmitted diseases: Overview of issues specific to adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/56/42886?source=related_link\">",
"      Urine collection techniques in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/45/6874?source=related_link\">",
"      Vulvar lichen sclerosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/29/26072?source=related_link\">",
"      Vulvovaginal complaints in the prepubertal child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_29_43480="Renal transplantation and the elderly patient";
var content_f42_29_43480=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Renal transplantation and the elderly patient",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/29/43480/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/29/43480/contributors\">",
"     Daniel C Brennan, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/29/43480/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/29/43480/contributors\">",
"     Barbara Murphy, MB, BAO, BCh, FRCPI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/29/43480/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/29/43480/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/29/43480/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important outcomes with any form of renal replacement therapy are patient survival and quality of life. In the younger patient, transplantation has three potential advantages when compared with dialysis:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Better quality of life",
"     </li>",
"     <li>",
"      Release from the tedium of dialysis",
"     </li>",
"     <li>",
"      Longer survival",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17992?source=see_link\">",
"     \"Patient survival after renal transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, among the elderly with end-stage renal disease (ESRD), it remains unclear whether the possible benefits with transplantation are sufficiently great for the clinician to advocate transplantation over dialysis.",
"   </p>",
"   <p>",
"    Additional aspects of renal transplantation that may differ in the elderly patient include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ethics of transplantation",
"     </li>",
"     <li>",
"      Pretransplant evaluation",
"     </li>",
"     <li>",
"      Mechanisms of graft loss and death",
"     </li>",
"     <li>",
"      Degree and type of immunosuppressive therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In general, transplant recipients are getting older. In the 2008 Scientific Registry of Transplant Recipients report, for example, recipients of deceased non-extended criteria donor kidneys in 2007 who were between age 50 to 64 years and 65 years and older constituted 39 and 13 percent of the total pool, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/1\">",
"     1",
"    </a>",
"    ]. By comparison, these age groups comprised only 29 and 5 percent of all such recipients in 1993, respectively.",
"   </p>",
"   <p>",
"    A discussion of renal transplantation in the elderly will be presented in this topic review. Issues relating to the use of a deceased donor kidney from an older donor and living related transplantation in the elderly will also be discussed. General issues relating to the potential recipient of a donor kidney are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/55/26490?source=see_link\">",
"     \"Evaluation of the potential renal transplant recipient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETHICS OF TRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians have been reluctant to transplant kidneys into elderly patients for a number of reasons. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The limited life expectancy of the elderly in general and the elderly patient with ESRD in particular.",
"     </li>",
"     <li>",
"      Poor results of renal transplantation with previous immunosuppressive regimens. In the precyclosporine era, for example, five year patient and graft survival were only 53 and 47 percent, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/2\">",
"       2",
"      </a>",
"      ]. In the modern era, however, both patient and graft five year survival among the elderly have markedly improved [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/1,3\">",
"       1,3",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Overview'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      The misconception that age alone negatively influences successful transplantation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At present, the most important reason for the reluctance to transplant elderly individuals is the current gross mismatch between the demand and supply for organs. The organ donor shortage in the United States is chronic, persistent, and increasing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This shortage of donor organs is not unique to the United States, as similar shortages exist in the United Kingdom and other European countries. Despite this ongoing worldwide shortage, an increasing number of older patients desire and benefit from a transplant. This demand is due to the combination of increasing success with organ transplantation and the increasing numbers of elderly patients with ESRD.",
"   </p>",
"   <p>",
"    The disparity between supply and demand has inevitably led some nephrologists to feel that younger patients should have priority over older individuals in acquiring deceased donor kidneys. Although understandable, others think that this view is unjustifiable. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/7/5240?source=see_link\">",
"     \"Organ sharing in kidney transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/62/11240?source=see_link\">",
"     \"The kidney transplant waiting list\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TRANSPLANTATION VERSUS DIALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A paucity of data exists concerning the relative mortality with dialysis versus transplantation for the elderly patient with ESRD. There is a similar lack of data concerning the relative effects on quality of life.",
"   </p>",
"   <p>",
"    Due to the overall perceived advantages, some clinicians suggest that, in the absence of contraindications, transplantation should be offered as renal replacement therapy to all patients independent of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Survival",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many older studies comparing survival after renal transplantation to continued dialysis were tainted by methodologic flaws, such as selection bias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. However, subsequent reports that have limited these methodologic problems show a survival advantage with transplantation among the elderly, including recipients of extended criteria donor kidneys [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/7-13\">",
"     7-13",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the largest, most comprehensive study to date, survival analysis using data from the United States Renal Data System (USRDS) was performed on nearly 230,000 dialysis patients, of whom nearly 40 percent were older than 60 years of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/7\">",
"       7",
"      </a>",
"      ]. Among the 6900 elderly patients placed on a waiting list for transplantation, approximately 3000 subsequently underwent a first cadaveric transplant. Difficulties with selection bias were overcome by directly comparing the survival of transplant recipients with that of waiting-list patients. Among those 60 to 74 years of age, the relative risk of death at 18 months posttransplantation was significantly",
"      <strong>",
"       lower",
"      </strong>",
"      among transplant recipients compared with waiting-list patients (RR of 0.37). This survival advantage also extended to elderly diabetics. The principal reason for the survival benefit with transplantation may have been the impact of current immunosuppressive regimens on transplant outcomes.",
"     </li>",
"     <li>",
"      In a study of 5667 wait-list patients older than 70 years of age, the risk of death was significantly lower with deceased donor transplantation versus remaining on the wait list (relative risk of 0.59) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/12\">",
"       12",
"      </a>",
"      ]. This benefit extended to those who received an expanded criteria donor kidney (RR of 0.75).",
"     </li>",
"     <li>",
"      A similar substantial survival benefit with transplantation was observed in another, much smaller study of patients over 60 years of age in Scotland [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/10\">",
"       10",
"      </a>",
"      ]. Among 325 patients placed on a renal transplant waiting list, the 1, 5, and 7 year survival was 81, 30, and 15 percent for patients continued on dialysis, respectively, versus 93, 73, and 46 percent for those who underwent transplantation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is estimated that, among those aged 60 to 74 years of age, projected remaining years of life are approximately 6 and 10 years for those who remain on a wait list or undergo renal transplant, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues surrounding overall survival, causes of death, and outcomes related to type of donor are discussed below. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Patient and graft outcomes'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Quality of life",
"    </span>",
"    &nbsp;&mdash;&nbsp;Successful renal transplantation improves overall quality of life, relieves the burden and tedium of dialysis, and may even improve cognitive function among all patients with ESRD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/7,14\">",
"     7,14",
"    </a>",
"    ]. However, insufficient information exists as to the impact of transplantation on the energy level and quality of life of the elderly patient. One study, for example, found that the average recipient 60 years of age and older did not gain strength (quadriceps and grip strength, and stepping up on a chair) in the first year after transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Findings of improved well-being after transplantation may also be due in part to the amelioration of anemia. This association has been noted in dialysis patients in whom successful treatment of anemia with erythropoietin is strongly associated with a significant improvement in general well-being. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/45/33496?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/31/5626?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients\"",
"    </a>",
"    .) Specific physical, mental and cardiac functions are also significantly enhanced among these patients, including the elderly. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/31/29174?source=see_link\">",
"     \"Hemodialysis in the elderly patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATIENT SELECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A comprehensive preoperative evaluation of the prospective elderly transplant recipient is imperative for two reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Graft loss in the elderly is related primarily to patient death.",
"     </li>",
"     <li>",
"      The two main causes of morbidity and mortality following transplantation are cardiovascular disease and infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A discussion of the evaluation of the general transplant recipient is presented separately, with reviews of some age-related issues. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/55/26490?source=see_link\">",
"     \"Evaluation of the potential renal transplant recipient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     IMMUNOSUPPRESSIVE THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of any immunosuppression protocol should be attaining an immunosuppressive level necessary for a reduced risk for infection but without increasing the risk of rejection. Immunosuppressive therapy must be modified in the elderly transplant recipient since immunocompetence lessens, thereby resulting in a decreased likelihood of immunologic rejection but increasing the risk of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Modified immunosuppressive therapy is particularly important in the elderly for two reasons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Infection is the leading cause of death in some reports.",
"     </li>",
"     <li>",
"      The most common cause of graft loss is death with a functioning graft (see below).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Immunosuppressive therapy must also be changed since the pharmacokinetics and effects of drugs are altered in the elderly. As an example, initial",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    doses, if given, should be reduced because, at any given dose, higher than normal blood levels result from a decline in cytochrome P450 activity. In addition if corticosteroids are given, we recommend a rapid",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    taper to a low maintenance dose, since corticosteroids have many untoward effects in the elderly.",
"   </p>",
"   <p>",
"    Treatment of acute rejection may also underlie the increased incidence of infections and infectious death among the elderly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/20\">",
"     20",
"    </a>",
"    ]. Although the relative incidence of acute rejection among the elderly is unclear, increased immunosuppression to suppress rejection may increase vulnerability to infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Induction therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A paucity of data exists concerning the benefits and adverse effects associated with different induction regimens in the elderly. If induction therapy is administered, the choice of agent is unclear and largely based upon findings in younger individuals.",
"   </p>",
"   <p>",
"    A retrospective analysis of United Network of Organ Sharing (UNOS) data from 2003-2008 suggested a higher risk of rejection and graft loss associated with interleukin-2 receptor antagonists compared with rabbit anti-thymocyte globulin (rATG) among high-risk elderly (&gt;60 years) recipients who received high risk kidneys [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/22\">",
"     22",
"    </a>",
"    ]. A high-risk recipient was defined as one having a peak panel reactive antibody &gt;20 percent, or a prior kidney transplantation, or of black race. High risk donor kidneys included expanded criteria donor kidneys, kidneys following cardiac death, or kidneys having a cold ischemia time greater than 24 hours. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Use of an older donor kidney and extended criteria donors'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    There did not appear to be any difference in outcomes among low risk elderly patients who received low risk kidneys, although there was a higher risk of rejection if either the recipient or donor was high risk. Randomized trials are necessary to better define the optimal induction regimen for elderly transplant recipients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Maintenance therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal combination of medications for maintenance immunosuppression among the elderly is unknown. However, some studies suggest that lower levels of immunosuppression may be sufficient in elderly patients to achieve adequate patient and graft survival without incurring increased rates of rejection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Regimens that spare calcineurin-inhibitors have been advocated among the elderly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/16\">",
"     16",
"    </a>",
"    ]. However, such regimens, as well as those associated with the withdrawal of calcineurin inhibitors, have been associated with an increased incidence of acute rejection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/23-25\">",
"     23-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A paucity of data exists concerning the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    in the elderly. Some findings suggest worse outcomes, while others report benefits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective study of 91 elderly transplant recipients, a regimen consisting of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"       mycophenolate",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      resulted in a higher rate of infectious complications than that associated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      , prednisone, and cyclosporine [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/26\">",
"       26",
"      </a>",
"      ]. A similar increased rate of infections with mycophenolate compared with azathioprine was reported in a second retrospective study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A retrospective study of over 5000 elderly transplant patients found that, compared with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"       mycophenolate",
"      </a>",
"      was associated with improved patient and allograft survival and lower rates of acute rejection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/28\">",
"       28",
"      </a>",
"      ]. However, these results must be interpreted with caution since azathioprine was principally used during a period in which overall transplant results were inferior for a variety of reasons.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Overall, there is currently little concern about the use of the combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil and a calcineurin inhibitor in most elderly patients given the view that these agents provide expected benefits in this patient population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Approaches to immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the absence of well-controlled prospective data, we suggest the following approach to immunosuppression in the elderly, which is based upon the risks of acute rejection, infections, malignancy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    comorbid conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/20\">",
"     20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antibody induction &mdash; We administer rATG-thymoglobulin rather than an interleukin-2 receptor antagonist to most elderly patients undergoing kidney transplantation. Exceptions may be made for patients who are unable to tolerate rATG, for example those presenting for transplant with hypotension, leucopenia or thrombocytopenia. Caucasian recipients of two haplotype identical living related kidneys, and recipients who have another function solid organ transplant and are already on immunosuppressive agents. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/56/32649?source=see_link\">",
"       \"Induction immunosuppressive therapy in renal transplantation in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      High risk recipient &mdash; Since minimizing immunosuppressive regimens may not be appropriate, a standard regimen consisting of antibody induction, corticosteroids, calcineurin inhibitors, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"       mycophenolate",
"      </a>",
"      mofetil is a reasonable regimen in these patients. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43706?source=see_link\">",
"       \"Maintenance immunosuppressive therapy in renal transplantation in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Low risk recipient of a kidney from a young donor &mdash; Such patients may be candidates for steroid minimization strategies, given the low risk of rejection and increased risk of steroid-induced adverse effects. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/4/21577?source=see_link\">",
"       \"Withdrawal or avoidance of glucocorticoids after renal transplantation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Low risk recipient of a kidney from an older donor &mdash; Calcineurin inhibitor minimization strategies may be appropriate in such elderly recipients, given the enhanced risk of chronic allograft nephropathy and nephrotoxicity with these agents. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=see_link\">",
"       \"Chronic renal allograft nephropathy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PATIENT AND GRAFT OUTCOMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal allograft and patient survival in the elderly transplant recipient are currently excellent.",
"   </p>",
"   <p>",
"    With present therapy, patient survival at one, five, and ten years is approximately 80 to 90, 70, and 50 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/1,3,17,19,29-38\">",
"     1,3,17,19,29-38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patient survival varies in part based upon the type of allograft. Based upon the 2006 Scientific Registry of Transplant recipients, the one, three, and five year patient survival rates for those 65 years of age and older are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      95, 88, and 77 percent for recipients of living donor kidney transplants, respectively",
"     </li>",
"     <li>",
"      93, 81, and 65 percent for recipients of deceased donor non-extended criteria donor kidneys, respectively",
"     </li>",
"     <li>",
"      86, 76, and 55 percent for recipients of deceased donor extended criteria donor kidneys, respectively",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Graft survival has increased in parallel, averaging 85 percent at one year and 70 percent at five years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/3,29\">",
"     3,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The association between graft survival and age is U-shaped with the lowest rate of graft failure among those between 55 to 65 years of age. This was shown in an analysis of 145,470 adult transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/39\">",
"     39",
"    </a>",
"    ]. Compared with patients between the ages of 55 to 65, the adjusted risk of death-censored graft failure was higher in those 75 years and older (hazard ratio (HR) 1.30, 95% CI 1.09-1.56), 35 to 55 years (HR 1.13, 95% CI 1.08-1.17), and 18 to 35 years (HR 1.64, 95% CI 1.57-1.71). Compared with those ages 18 to 35, the risk of death-censored graft failure was lower among those between ages 65 to 70 (HR 0.63, 95% CI 0.59-0.68) and 70 to 75 (HR 0.64, 95% CI 0.57-0.71) and older than 75 years (HR 0.80, 95% CI 0.67-0.95).",
"   </p>",
"   <p>",
"    Allograft survival varies with type of allograft, as noted in the 2006 Scientific Registry of Transplant recipients database [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/1\">",
"     1",
"    </a>",
"    ]. Allograft survival rates at one, three, and five years for those 65 years of age and older are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      93, 84, and 70 percent for recipients of living donor kidney transplants, respectively",
"     </li>",
"     <li>",
"      89, 75, and 60 percent for recipients of deceased donor non-extended criteria donor kidneys, respectively",
"     </li>",
"     <li>",
"      80, 66, and 46 percent for recipients of deceased donor extended criteria donor kidneys, respectively",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Graft loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient death with a functioning allograft accounts for the majority of \"graft loss\" in older transplant patients. When older and younger patients are compared, for example, nearly 50 percent of graft loss in older individuals occurs due to death versus approximately 15 percent in younger patients.",
"   </p>",
"   <p>",
"    Acute rejection may occur less commonly in older patients, a finding that may be attributable to age-related \"tolerance\". It accounts for a smaller percentage of graft loss in the elderly than that observed in younger patients.",
"   </p>",
"   <p>",
"    There is also an increased risk of chronic allograft nephropathy in the elderly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/40\">",
"     40",
"    </a>",
"    ]. This is enhanced if the allograft is from an older donor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Causes of death",
"    </span>",
"    &nbsp;&mdash;&nbsp;The predominant causes of death in elderly transplant recipients are infection and cardiovascular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/16,41\">",
"     16,41",
"    </a>",
"    ]. A majority of infectious episodes occur in the first six months posttransplant, being related to the degree of immunosuppression.",
"   </p>",
"   <p>",
"    The enhanced risks of immunosuppression and cardiovascular disease are due in part to the natural effects of aging, and to issues unique to the elderly patient with ESRD. Older subjects have an increased incidence of underlying cardiovascular disease and an enhanced number of cardiovascular risk factors, resulting in an increased risk of death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/42\">",
"     42",
"    </a>",
"    ]. In addition, some risk factors for heart disease, such as hypertension and diabetes mellitus, may be exacerbated or induced by immunosuppressive medications or may be found with increased frequency in elderly patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/0/29703?source=see_link\">",
"     \"Risk factors and epidemiology of coronary artery disease in end-stage renal disease (dialysis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A greater degree of immunosuppression results in an increased risk of infectious complications in all patients (young and old). However, as previously mentioned, immunocompetence decreases with age; as a result, older individuals are more susceptible to infectious complications at lower levels of immunosuppressive therapy. The most prominent culprits are high dose corticosteroids and antilymphocyte antibodies in the induction immunosuppressive regimen.",
"   </p>",
"   <p>",
"    Other causes of death in older patients should not be ignored. Older transplant recipients have a high rate of death due to malignancy and gastrointestinal hemorrhage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/16\">",
"     16",
"    </a>",
"    ]. Death due to malignancy appears to increase disproportionately with time post-transplantation among older versus younger allograft recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the enhanced risk of death from these different causes, renal transplantation still provides a better chance of survival than dialysis. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Survival'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Use of an older donor kidney and extended criteria donors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kidney procurement from the elderly would help ameliorate the paucity of available organs. In addition to the use of older deceased donor kidneys, kidneys from older subjects can also be used for living donor transplantation. Many centers within the United States evaluate potential older donors independent of age. In 2004, for example, one and seven percent of all living and deceased kidneys were from donors older than 65 years of age, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some data have demonstrated that recipients of older living donor kidneys have, on average, shorter graft survivals and lower glomerular filtration rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/43-48\">",
"     43-48",
"    </a>",
"    ]. This was perhaps best reported in a study from the United States Renal Data System of over 73,000 first kidney only transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/47\">",
"     47",
"    </a>",
"    ]. At three and five years, allograft survival from older living donors (greater than 55 years of age) was 85 and 76 percent, respectively. By comparison, survival was 89 and 82 percent from younger living donors (less than 55 years of age), respectively. A lower risk of allograft loss after living donation was also noted with living donors 55 to 64 years of age versus that with relatively older donors aged 64 to 69 years (HR 1.3, 95% CI 1.1-1.7) and donors greater than 70 years (HR 1.7, 95% CI 1.1-2.6).",
"   </p>",
"   <p>",
"    Several factors probably account for the inferior graft outcome with the older donor kidney. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Impaired renal function due to aging",
"     </li>",
"     <li>",
"      Greater susceptibility of the older kidney to damage from ischemia, rejection, and calcineurin-inhibitors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among older recipients, some data also suggest that increased survival may be noted with decreased age of the deceased donor. This was reported in a review of over 50,000 renal transplant recipients from the United Network of Organ Sharing database [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/49\">",
"     49",
"    </a>",
"    ]. Among recipients greater than 55 years of age, donor age group between 0 to 17, 18 to 29, 30 to 41, 42 to 54, and greater than 55 years of age was associated with an adjusted 10 year patient survival of 48, 46, 45, 37, and 35 percent, respectively.",
"   </p>",
"   <p>",
"    Although graft function, allograft survival, and perhaps patient survival may be adversely affected by the older donor, the results are still acceptable, including patient and graft outcomes from older living kidney donors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/25,43,46-48,50\">",
"     25,43,46-48,50",
"    </a>",
"    ]. This has led to the following conclusions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The donor pool should be expanded.",
"     </li>",
"     <li>",
"      Older kidneys might be harvested for particular use in the older recipient, a setting in which 20 to 30 year graft survival is not as important as in younger recipients.",
"     </li>",
"     <li>",
"      Routine periharvest renal core biopsies should be used to evaluate the integrity of renal anatomy in donors between 60 to 65 years of age. This procedure might alter the disparity between graft function and outcome in the older donor.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to periharvest renal biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/51\">",
"     51",
"    </a>",
"    ], the successful use of older kidneys can be enhanced by: excluding such kidneys when the plasma creatinine concentration is greater than 1.8 to 2.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (159 to 177",
"    <span class=\"nowrap\">",
"     micromol/L);",
"    </span>",
"    restricting the use of these kidneys to unsensitized patients receiving a first graft; and minimizing, if feasible, other risk factors for acute tubular necrosis, such as hemodynamic stability and total ischemic time. In addition, limited evidence also suggests that, to maximize the number of functioning nephrons, transplanting two older kidneys, rather than one, in one recipient may help improve outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These observations suggest that a change in allocation policy in which the life expectancy of the transplant recipient is matched roughly with the expected survival of the kidney allograft may provide societal benefits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/54\">",
"     54",
"    </a>",
"    ]. Benefits would include reducing both the number of kidneys wasted due to death of the recipient with a functioning allograft and the number of retransplant procedures due to the loss of allograft function in a younger patient.",
"   </p>",
"   <p>",
"    Along these lines, the Organ Procurement Transplant Network has instituted a policy in which kidneys from donors with some adverse features, such as increased age, history of hypertension, death from stroke or an elevated serum creatinine concentration, would be allowed to be transplanted. These are referred to as extended donor criteria. As previously mentioned, patient survival among the elderly transplant recipient is significantly better with an extended criteria donor (ECD) kidney than in those who remain on the wait list [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Survival'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/7/5240?source=see_link\">",
"     \"Organ sharing in kidney transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In an analysis of the Scientific Registry of Transplant recipients database, among patients older than 70 years of age, transplantation of an ECD kidney was not associated with significantly increased mortality compared with a non-ECD kidney (HR 1.12, 95% CI 0.93-1.36 for patients between 70 to &lt;75 years, and 1.04, 95% CI 0.74-1.47 for patients older than 75 years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/39\">",
"     39",
"    </a>",
"    ]. Transplantation of an ECD kidney was associated with increased mortality for patients younger than 70 years however. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/62/11240?source=see_link&amp;anchor=H12#H12\">",
"     \"The kidney transplant waiting list\", section on 'Expanded donor kidneys'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Eurotransplant Senior Programme (ESP) has also instituted a policy in which organs retrieved from donors older than 65 years of age are allocated to those of similar age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/23,55-59\">",
"     23,55-59",
"    </a>",
"    ]. Data from this program revealed that, among 1406 patients, similar graft and patient survival have been realized in a five year analysis compared with standard allocation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Long-term patient and allograft survival with dual kidney transplants obtained via an expanded donor criteria program appears to be equivalent to those who undergo standard single-kidney transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. One study, for example, reported outcomes at eight years post-transplant of 61 and 31 patients aged 55 years and older who received single or double expanded donor criteria renal transplants, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43480/abstract/60\">",
"     60",
"    </a>",
"    ]. Patient survival was 74 and 82 percent after single and dual kidney transplants, respectively, while allograft survival was 49 and 70 percent, respectively. These outcomes after dual kidney transplants are comparable to those reported with standard single kidney transplants.",
"   </p>",
"   <p>",
"    The UNOS Kidney Allocation Review Subcommittee has also proposed changing the deceased donor allocation policy to one that would increase the \"net lifetime survival benefit\". This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/7/5240?source=see_link\">",
"     \"Organ sharing in kidney transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1456894085\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Compared with dialysis, there is a survival advantage associated with transplantation among elderly patients. It is estimated that, among those aged 60 to 74 years of age, projected remaining years of life are approximately 6 and 10 years for those who remain on a wait list or undergo renal transplant, respectively. If allograft survival is censored for patient death, overall allograft survival is similar among the elderly and younger recipients. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Survival'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Successful renal transplantation improves overall quality of life and relieves the burden and tedium of dialysis among all patients with ESRD although it is not known whether transplantation improves the energy level of the elderly patient. Due to the overall advantages, some clinicians suggest that, in the absence of contraindications, transplantation should be offered as renal replacement therapy to all patients independent of age if the estimated five year survival exceeds 50 percent. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Transplantation versus dialysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Maintenance immunosuppressive therapy must be modified in the elderly transplant recipient since immunocompetence lessens with age, thereby resulting in a decreased likelihood of immunologic rejection but increased risk of infection. Immunosuppressive therapy must also be changed since the pharmacokinetics and effects of drugs are altered in the elderly. We suggest the following approach:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For most low-risk elderly recipients we suggest induction therapy with rATG-thymoglobulin rather than an interleukin-2 receptor antagonist. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Approaches to immunosuppression'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/56/32649?source=see_link\">",
"       \"Induction immunosuppressive therapy in renal transplantation in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For high-risk elderly recipients, we suggest a standard induction regimen consisting of antibody induction, corticosteroids, calcineurin inhibitors, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"       mycophenolate",
"      </a>",
"      mofetil. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Approaches to immunosuppression'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43706?source=see_link\">",
"       \"Maintenance immunosuppressive therapy in renal transplantation in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Low risk elderly recipient of a kidney from a young donor may be candidates for steroid minimization strategies, given the low risk of rejection and increased risk of steroid-induced adverse effects. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/4/21577?source=see_link\">",
"       \"Withdrawal or avoidance of glucocorticoids after renal transplantation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Low risk recipient of a kidney from an older donor may be treated with calcineurin inhibitor minimization strategies, given the enhanced risk of chronic allograft nephropathy and nephrotoxicity with these agents. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Approaches to immunosuppression'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=see_link\">",
"       \"Chronic renal allograft nephropathy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Renal allograft and patient survival in the elderly transplant recipient are currently excellent. With present therapy, patient survival at one, five, and ten years is approximately 80 to 90, 70, and 50 percent, respectively. Living donor kidney transplants are associated with the best patient and graft survival. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Patient and graft outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The predominant causes of death in elderly transplant recipients are infection and cardiovascular disease. A majority of infectious episodes occur in the first six months posttransplant. Older transplant recipients also have a high rate of death due to malignancy and gastrointestinal hemorrhage. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Causes of death'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Kidney procurement from the elderly would help ameliorate the paucity of available organs. Some data have demonstrated that recipients of older living donor kidneys have, on average, shorter graft survivals and lower glomerular filtration rates. An allocation policy in which the life expectancy of the transplant recipient is matched roughly with the expected survival of the kidney allograft may provide societal benefits. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Use of an older donor kidney and extended criteria donors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16684967\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Nuhad Ismail, MD, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     The 2008 SRTR report on the state of transplantation. Accessed February, 2010. www.ustransplant.org/annual_reports.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/2\">",
"      Ismail N, Hakim RM, Helderman JH. Renal replacement therapies in the elderly: Part II. Renal transplantation. Am J Kidney Dis 1994; 23:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/3\">",
"      Fabrizii V, Winkelmayer WC, Klauser R, et al. Patient and graft survival in older kidney transplant recipients: does age matter? J Am Soc Nephrol 2004; 15:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/4\">",
"      Taube DH, Winder EA, Ogg CS, et al. Successful treatment of middle aged and elderly patients with end stage renal disease. Br Med J (Clin Res Ed) 1983; 286:2018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/5\">",
"      Fauchald P, Albrechtsen D, Leivestad T, et al. Renal replacement therapy in elderly patients. Transpl Int 1988; 1:131.",
"     </a>",
"    </li>",
"    <li>",
"     US Renal Data System, 1993 Annual Data Report, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/7\">",
"      Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341:1725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/8\">",
"      Hunsicker LG. A survival advantage for renal transplantation. N Engl J Med 1999; 341:1762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/9\">",
"      Johnson DW, Herzig K, Purdie D, et al. A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients. Transplantation 2000; 69:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/10\">",
"      Oniscu GC, Brown H, Forsythe JL. How great is the survival advantage of transplantation over dialysis in elderly patients? Nephrol Dial Transplant 2004; 19:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/11\">",
"      Giessing M, Budde K, Fritsche L, et al. \"Old-for-old\" cadaveric renal transplantation: surgical findings, perioperative complications and outcome. Eur Urol 2003; 44:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/12\">",
"      Rao PS, Merion RM, Ashby VB, et al. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation 2007; 83:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/13\">",
"      Savoye E, Tamarelle D, Chalem Y, et al. Survival benefits of kidney transplantation with expanded criteria deceased donors in patients aged 60 years and over. Transplantation 2007; 84:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/14\">",
"      Radi�� J, Ljuti�� D, Radi�� M, et al. Kidney transplantation improves cognitive and psychomotor functions in adult hemodialysis patients. Am J Nephrol 2011; 34:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/15\">",
"      Nyberg G, Nilsson B, Nord&eacute;n G, Karlberg I. Outcome of renal transplantation in patients over the age of 60: a case-control study. Nephrol Dial Transplant 1995; 10:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/16\">",
"      Martins PN, Pratschke J, Pascher A, et al. Age and immune response in organ transplantation. Transplantation 2005; 79:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/17\">",
"      Velez RL, Brinker KR, Vergne-Marini PJ, et al. Renal transplantation with cyclosporine in the elderly population. Transplant Proc 1991; 23:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/18\">",
"      European Best Practice Guidelines for Renal Transplantation (Part 2). Nephrol Dial Transplant 2002; 17(Suppl 4):58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/19\">",
"      DeLuca, L, Cardella, CJ. How can the care of elderly dialysis patients be improved?. Semin Dial 1992; 5:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/20\">",
"      Danovitch GM, Gill J, Bunnapradist S. Immunosuppression of the elderly kidney transplant recipient. Transplantation 2007; 84:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/21\">",
"      Meier-Kriesche HU, Ojo A, Hanson J, et al. Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation 2000; 69:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/22\">",
"      Gill J, Sampaio M, Gill JS, et al. Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States. Clin J Am Soc Nephrol 2011; 6:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/23\">",
"      Smits JM, Persijn GG, van Houwelingen HC, et al. Evaluation of the Eurotransplant Senior Program. The results of the first year. Am J Transplant 2002; 2:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/24\">",
"      Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11:1910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/25\">",
"      Fritsche L, H&ouml;rstrup J, Budde K, et al. Old-for-old kidney allocation allows successful expansion of the donor and recipient pool. Am J Transplant 2003; 3:1434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/26\">",
"      Meier-Kriesche HU, Friedman G, Jacobs M, et al. Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols. Transplantation 1999; 68:1496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/27\">",
"      Johnson DW, Nicol DL, Purdie DM, et al. Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients? Transplantation 2002; 73:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/28\">",
"      Meier-Kriesche HU, Morris JA, Chu AH, et al. Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients. Nephrol Dial Transplant 2004; 19:2864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/29\">",
"      Oniscu GC, Brown H, Forsythe JL. How old is old for transplantation? Am J Transplant 2004; 4:2067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/30\">",
"      Pirsch JD, Stratta RJ, Armbrust MJ, et al. Cadaveric renal transplantation with cyclosporine in patients more than 60 years of age. Transplantation 1989; 47:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/31\">",
"      Kauffman HM, McBride MA, Cors CS, et al. Early mortality rates in older kidney recipients with comorbid risk factors. Transplantation 2007; 83:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/32\">",
"      Morris GE, Jamieson NV, Small J, et al. Cadaveric renal transplantation in elderly recipients: is it worthwhile? Nephrol Dial Transplant 1991; 6:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/33\">",
"      Tesi RJ, Elkhammas EA, Davies EA, et al. Renal transplantation in older people. Lancet 1994; 343:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/34\">",
"      Roodnat JI, Zietse R, Mulder PG, et al. The vanishing importance of age in renal transplantation. Transplantation 1999; 67:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/35\">",
"      Doyle SE, Matas AJ, Gillingham K, Rosenberg ME. Predicting clinical outcome in the elderly renal transplant recipient. Kidney Int 2000; 57:2144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/36\">",
"      Saudan P, Berney T, Leski M, et al. Renal transplantation in the elderly: a long-term, single-centre experience. Nephrol Dial Transplant 2001; 16:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/37\">",
"      Cohen DJ, St Martin L, Christensen LL, et al. Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant 2006; 6:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/38\">",
"      Bentas W, Jones J, Karaoguz A, et al. Renal transplantation in the elderly: surgical complications and outcome with special emphasis on the Eurotransplant Senior Programme. Nephrol Dial Transplant 2008; 23:2043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/39\">",
"      Molnar MZ, Streja E, Kovesdy CP, et al. Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis 2012; 59:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/40\">",
"      Meier-Kriesche HU, Cibrik DM, Ojo AO, et al. Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc 2002; 50:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/41\">",
"      Trouillhet I, Benito N, Cervera C, et al. Influence of age in renal transplant infections: cases and controls study. Transplantation 2005; 80:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/42\">",
"      Kappes U, Schanz G, Gerhardt U, et al. Influence of age on the prognosis of renal transplant recipients. Am J Nephrol 2001; 21:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/43\">",
"      Alexander JW, Bennett LE, Breen TJ. Effect of donor age on outcome of kidney transplantation. A two-year analysis of transplants reported to the United Network for Organ Sharing Registry. Transplantation 1994; 57:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/44\">",
"      Basar H, Soran A, Shapiro R, et al. Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation 1999; 67:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/45\">",
"      Woo YM, Gill JS, Johnson N, et al. The advanced age deceased kidney donor: current outcomes and future opportunities. Kidney Int 2005; 67:2407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/46\">",
"      De La Vega LS, Torres A, Bohorquez HE, et al. Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR. Kidney Int 2004; 66:1654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/47\">",
"      Gill JS, Gill J, Rose C, et al. The older living kidney donor: Part of the solution to the organ shortage. Transplantation 2006; 82:1662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/48\">",
"      Gill J, Bunnapradist S, Danovitch GM, et al. Outcomes of kidney transplantation from older living donors to older recipients. Am J Kidney Dis 2008; 52:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/49\">",
"      Keith DS, Demattos A, Golconda M, et al. Effect of donor recipient age match on survival after first deceased donor renal transplantation. J Am Soc Nephrol 2004; 15:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/50\">",
"      Foss A, Heldal K, Scott H, et al. Kidneys from deceased donors more than 75 years perform acceptably after transplantation. Transplantation 2009; 87:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/51\">",
"      Randhawa P. Role of donor kidney biopsies in renal transplantation. Transplantation 2001; 71:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/52\">",
"      Remuzzi G, Griny&ograve; J, Ruggenenti P, et al. Early experience with dual kidney transplantation in adults using expanded donor criteria. Double Kidney Transplant Group (DKG). J Am Soc Nephrol 1999; 10:2591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/53\">",
"      Lu AD, Carter JT, Weinstein RJ, et al. Outcome in recipients of dual kidney transplants: an analysis of the dual registry patients. Transplantation 2000; 69:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/54\">",
"      Baskin-Bey ES, Kremers W, Nyberg SL. Improving utilization of deceased donor kidneys by matching recipient and graft survival. Transplantation 2006; 82:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/55\">",
"      Cohen B, Smits JM, Haase B, et al. Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant 2005; 20:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/56\">",
"      Rudge C. Long-term patient and graft survival in the eurotransplant senior program: a single-center experience. Transplantation 2005; 80:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/57\">",
"      Fabrizii V, Kovarik J, Bodingbauer M, et al. Long-term patient and graft survival in the eurotransplant senior program: a single-center experience. Transplantation 2005; 80:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/58\">",
"      Frei U, Noeldeke J, Machold-Fabrizii V, et al. Prospective age-matching in elderly kidney transplant recipients--a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/59\">",
"      Giessing M, Fuller TF, Friedersdorff F, et al. Outcomes of transplanting deceased-donor kidneys between elderly donors and recipients. J Am Soc Nephrol 2009; 20:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/60\">",
"      Tan JC, Alfrey EJ, Dafoe DC, et al. Dual-kidney transplantation with organs from expanded criteria donors: a long-term follow-up. Transplantation 2004; 78:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43480/abstract/61\">",
"      Moore PS, Farney AC, Sundberg AK, et al. Dual kidney transplantation: a case-control comparison with single kidney transplantation from standard and expanded criteria donors. Transplantation 2007; 83:1551.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7312 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.247-661AF214C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43480=[""].join("\n");
var outline_f42_29_43480=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1456894085\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETHICS OF TRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TRANSPLANTATION VERSUS DIALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Survival",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Quality of life",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATIENT SELECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      IMMUNOSUPPRESSIVE THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Induction therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Maintenance therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Approaches to immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PATIENT AND GRAFT OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Graft loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Causes of death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Use of an older donor kidney and extended criteria donors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1456894085\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16684967\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=related_link\">",
"      Chronic renal allograft nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/45/33496?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/31/5626?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/55/26490?source=related_link\">",
"      Evaluation of the potential renal transplant recipient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/31/29174?source=related_link\">",
"      Hemodialysis in the elderly patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/56/32649?source=related_link\">",
"      Induction immunosuppressive therapy in renal transplantation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43706?source=related_link\">",
"      Maintenance immunosuppressive therapy in renal transplantation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/7/5240?source=related_link\">",
"      Organ sharing in kidney transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/36/17992?source=related_link\">",
"      Patient survival after renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/0/29703?source=related_link\">",
"      Risk factors and epidemiology of coronary artery disease in end-stage renal disease (dialysis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/62/11240?source=related_link\">",
"      The kidney transplant waiting list",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/4/21577?source=related_link\">",
"      Withdrawal or avoidance of glucocorticoids after renal transplantation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_29_43481="Esophagectomy: Complications and management";
var content_f42_29_43481=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Esophagectomy: Complications and management",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/29/43481/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/29/43481/contributors\">",
"     Daniel P Raymond, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/29/43481/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/29/43481/contributors\">",
"     Joseph S Friedberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/29/43481/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/29/43481/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/29/43481/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H89118788\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal resection and restoration of gastrointestinal continuity operations are technically challenging procedures. This topic will discuss the clinical and nonclinical risk factors associated with an increased risk of morbidity and mortality and the management of the complications following an esophagectomy. The surgical resection procedures are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=see_link\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7783803\">",
"    <span class=\"h1\">",
"     MORBIDITY AND MORTALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Morbidity and mortality rates vary, depending upon hospital",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    surgeon volume, patient comorbidities, and operative approach (eg, open, minimally invasive, tri-incisional) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. A review of all publications between 2005 and 2009 reporting on the morbidity and mortality of an esophagectomy (n = 57,299 patients) found heterogeneous and inconsistent reporting of data and a lack of methodological rigor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/5\">",
"     5",
"    </a>",
"    ]. For example, no one single complication was reported in all papers, and in-hospital mortality, the most common term for postoperative death, had six different definitions. Meaningful cross study comparisons and analyses are challenging.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8261725\">",
"    <span class=\"h2\">",
"     Overall morbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall postoperative morbidity rates range from 20 to 80 percent and include respiratory (eg, pneumonia) and cardiac (eg, infarction, failure, atrial fibrillation) complications, anastomotic leaks, recurrent laryngeal nerve injury, and minor complications (eg, urinary tract infections, atelectasis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/2-4,6-13\">",
"     2-4,6-13",
"    </a>",
"    ]. The most common serious complications include a major anastomotic leak, which occurs in 0 to 40 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/7,14,15\">",
"     7,14,15",
"    </a>",
"    ] and postoperative pulmonary complications, which occur in 16 to 67 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/7,16-18\">",
"     7,16-18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8263278\">",
"    <span class=\"h2\">",
"     Overall mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall in-hospital mortality rates range from 0 to 22 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/1,2,7,19-23\">",
"     1,2,7,19-23",
"    </a>",
"    ]. The overall 30-day mortality rates (excluding in-hospital deaths) range from &lt;1 to 6 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/19\">",
"     19",
"    </a>",
"    ]. In a prospective study of 615 patients who underwent an esophagectomy, the median survival was significantly shorter in patients who sustained surgical complications compared with those without complications (15 versus 22 months) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/8\">",
"     8",
"    </a>",
"    ]. Including only those who survived 90 days or longer postoperatively (n = 567), the risk of mortality was significantly increased in patients who sustained postoperative complications (hazard ratio [HR] = 1.29, 95% CI 1.02-1.63). Most patients who die following an esophagectomy experience multiple serious complications (median 2.5, range 1 to 8) rather than a single event [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H178439131\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon a multivariable logistic regression analysis of a prospective study that included 1777 patients undergoing an esophagectomy, several independent preoperative clinical factors have been identified that increase the risk of morbidity and mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Preoperative predictors of",
"    <strong>",
"     morbidity",
"    </strong>",
"    included [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Insulin-dependent diabetes mellitus",
"     </li>",
"     <li>",
"      Dyspnea with mild exertion",
"     </li>",
"     <li>",
"      Low serum albumin concentration",
"     </li>",
"     <li>",
"      Chronic obstructive pulmonary disease",
"     </li>",
"     <li>",
"      Current smoking",
"     </li>",
"     <li>",
"      Alkaline phosphatase &gt;125",
"      <span class=\"nowrap\">",
"       U/L",
"      </span>",
"     </li>",
"     <li>",
"      Increasing age (continuous variable)",
"     </li>",
"     <li>",
"      Decreased functional status (partially dependent)",
"     </li>",
"     <li>",
"      Emergency status",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Preoperative predictors of 30-day",
"    <strong>",
"     mortality",
"    </strong>",
"    included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ascites",
"     </li>",
"     <li>",
"      Increasing age (continuous variable)",
"     </li>",
"     <li>",
"      Insulin-dependent diabetes mellitus",
"     </li>",
"     <li>",
"      Decreased functional status (partially dependent)",
"     </li>",
"     <li>",
"      Neoadjuvant therapy",
"     </li>",
"     <li>",
"      Blood urea nitrogen (BUN) &gt;40",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"     </li>",
"     <li>",
"      Current alcohol use (&gt;2 drinks per day within 2 weeks)",
"     </li>",
"     <li>",
"      Alkaline phosphatase &gt;125",
"      <span class=\"nowrap\">",
"       U/L",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Preoperative indications for surgery (ie, malignant or benign disease) were not associated with mortality or morbidity. Patients with malignant disease had similar 30-day mortality and morbidity rates compared with patients with benign disease (9.7 versus 10.1 percent, and 49.0 versus 51.1 percent, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H178444755\">",
"    <span class=\"h3\">",
"     Comorbid illnesses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comorbid illnesses increase the risk of postoperative complications (eg, cardiorespiratory complications, anastomotic leakage, reoperation rates, wound infection), and death following esophagectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/8,24,25\">",
"     8,24,25",
"    </a>",
"    ]. For example, in a prospective study of 615 patients, those with comorbid illness have an increased rate of postoperative complications and major anastomotic leaks compared with patients without comorbidities (28 versus 18 percent and 11 versus &lt;1 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/8\">",
"     8",
"    </a>",
"    ]. In addition, a meta-regression analysis showed the risk of anastomotic leakage and atrial fibrillation in obese patients with diabetes was significantly higher compared with obese patients without diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H178444762\">",
"    <span class=\"h3\">",
"     Increasing age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prospective and retrospective studies using multivariable logistic regression analysis found that increasing age is independently associated with an increased risk of morbidity and mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/2,8,25,26\">",
"     2,8,25,26",
"    </a>",
"    ]. However, age alone should not determine operability. In a prospective analysis of 615 patients undergoing an esophagectomy, patients older than 75 years of age had a similar rate of complications compared with those 75 years and younger (29 of 110 patients [26 percent] versus 125 of 505 patients [25 percent]) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/8\">",
"     8",
"    </a>",
"    ]. The rate of a major anastomotic complication was also similar (12 patients [11 percent] versus 44 patients [9 percent]).",
"   </p>",
"   <p>",
"    Age is likely a crude surrogate of comorbid illness and should not be used alone to determine operability. Appropriately selected elderly patients can undergo esophagectomy with comparable outcomes to younger patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86572444\">",
"    <span class=\"h3\">",
"     Intraoperative variables",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraoperative blood transfusion predicted high morbidity and mortality, while a longer operative time predicted morbidity only [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H178436712\">",
"    <span class=\"h3\">",
"     Hospital volume",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who undergo esophagectomy at hospitals where the performance of larger numbers of esophagectomies have lower perioperative mortality rates and better early clinical outcomes than those who undergo resection at lower volume institutions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/9,19,20,27-33\">",
"     9,19,20,27-33",
"    </a>",
"    ]. As an example, in one report that used Medicare claims data, the mortality rate for patients undergoing esophagectomy at the highest volume hospitals (more than 19 procedures yearly) was significantly lower compared with patients operated upon at the lowest volume hospitals (fewer than two procedures yearly), (adjusted odds ratio 0.36, 95% CI 0.26-0.50) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/27\">",
"     27",
"    </a>",
"    ]. In a review of nine trials, patients operated upon at high-volume centers had lower in-hospital and 30-day mortality rates (2.82 versus 8.48 percent, and 0.73 versus 2.09 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Explaining these differences in outcome is challenging and likely multifactorial. Surgeon experience [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/34\">",
"     34",
"    </a>",
"    ], dedicated intensive care teams, nursing skill, respiratory therapy, resource allocation, multidisciplinary team management, clinical care pathways, and availability of costly diagnostic and therapeutic equipment are examples of variables which may be enhanced at high volume centers and thus translate into improved outcomes. Whether or not this variable impacts longer-term survival is uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/35-37\">",
"     35-37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89118810\">",
"    <span class=\"h1\">",
"     PULMONARY COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative pulmonary complications, such as pneumonia, chronic obstructive pulmonary disease (COPD), bronchospasm, acute respiratory distress syndrome, and ventilator dependency are the most frequent complications following esophagectomy, occurring in approximately 16 to 67 percent of all patients, and account for approximately two-thirds of postoperative esophagectomy mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/2,7,16,17,26,38\">",
"     2,7,16,17,26,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A multivariate analysis showed that pneumonia is an independent risk factor for postoperative esophagectomy mortality. In a retrospective review of 379 patients, the risk of death for patients who developed pneumonia was significantly higher compared with those who did not (20.0 versus 3.1 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/26\">",
"     26",
"    </a>",
"    ]. Increasing age was the only other variable independently associated with postoperative mortality.",
"   </p>",
"   <p>",
"    Factors contributing to postoperative pulmonary complications include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diminished airway protection",
"     </li>",
"     <li>",
"      Chronic aspiration due to impaired preoperative esophageal function",
"     </li>",
"     <li>",
"      Malnutrition",
"     </li>",
"     <li>",
"      Recurrent laryngeal nerve compromise",
"     </li>",
"     <li>",
"      Postoperative pain",
"     </li>",
"     <li>",
"      Postoperative dysphagia",
"     </li>",
"     <li>",
"      Duration of operative procedure",
"     </li>",
"     <li>",
"      Need for postoperative ventilatory support",
"     </li>",
"     <li>",
"      Altered mental status",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Preoperative, intraoperative, and postoperative measures that can reduce postoperative pulmonary complications include preoperative respiratory rehabilitation (eg, smoking cessation, inspiratory muscle training), postoperative lung expansion maneuvers, oral hygiene, postoperative pulmonary toilet, and meticulous pain management. Initial attempts at oral intake following esophagectomy should be supervised and liberal use of speech therapy services is encouraged in order to avoid aspiration events, especially in patients with a neck incision where the risk of recurrent laryngeal nerve injury is elevated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/51/13113?source=see_link\">",
"     \"Strategies to reduce postoperative pulmonary complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The operative approach itself may influence the risk of respiratory complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. For example, in a randomized trial of 220 patients with adenocarcinoma involving the mid to distal esophagus, patients undergoing a transthoracic esophagectomy were significantly more likely to experience pulmonary complications compared with patients undergoing a transhiatal approach (57 versus 27 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/39\">",
"     39",
"    </a>",
"    ]. In an open label, randomized trial of 115 patients, those undergoing an open transthoracic esophagectomy had a significantly higher rate of pulmonary complications compared with patients undergoing a minimally invasive esophagectomy (29 versus 9 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/40\">",
"     40",
"    </a>",
"    ]. A description of the esophagectomy procedures is provided in a separate topic. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=see_link&amp;anchor=H32960293#H32960293\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\", section on 'Operative procedures'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=see_link&amp;anchor=H191461974#H191461974\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\", section on 'Open versus minimally invasive'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A nasogastric tube (NGT) is typically inserted during an esophagectomy for gastric decompression and to protect against pulmonary complications, such as aspiration pneumonia. In a randomized trial of 150 patients undergoing an esophagectomy, early removal (48 hours) of the NGT was not associated with a statistically significant increase in pulmonary complications compared with conventional prolonged (6 to 10 days) management (13.3 versus 12.0 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/42\">",
"     42",
"    </a>",
"    ]. In addition, patients with early NGT removal had a similar rate of anastomotic complications (10.6 versus 8.0 percent). They also had lower discomfort scores but they more often required reinsertion of the NGT (30.7 versus 9.3 percent) to relieve gastric dilatation, vomiting, postoperative ileus,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anastomotic leaks. (See",
"    <a class=\"local\" href=\"#H92141763\">",
"     'Conduit-related disorders'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/16/9480?source=see_link\">",
"     \"Nasogastric and nasoenteric tubes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of postoperative pulmonary complications, including bronchospasm, acute exacerbations of asthma or chronic obstructive pulmonary disease, pneumonia, chemical pneumonitis, and acute respiratory distress syndrome, are reviewed as separate topics. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/10/11434?source=see_link\">",
"     \"Overview of the management of postoperative pulmonary complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92141763\">",
"    <span class=\"h1\">",
"     CONDUIT-RELATED DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemia and denervation of the conduit are the inherent complications of creating the neoesophagus. After mobilization of the stomach, Doppler scans have identified a decrease in perfusion at the proximal end of the gastric conduit by approximately 70 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/43\">",
"     43",
"    </a>",
"    ]. Compromised conduit perfusion may result in an anastomotic leak",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    stricture formation, conduit ischemia, and functional conduit disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92141770\">",
"    <span class=\"h2\">",
"     Anastomotic leak",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of an anastomotic leak ranges from 5 to 18 percent following esophagectomy and the associated mortality is approximately 12 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/7,14,15,44-51\">",
"     7,14,15,44-51",
"    </a>",
"    ]. In a retrospective review of 607 patients undergoing an esophagectomy with a thoracic anastomosis, a pedicled omental reinforcement of the anastomosis was associated with a significantly lower leak rate compared with no omental flap (4.7 versus 10.5 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several other variables have been implicated in the ultimate integrity of the anastomosis, including anastomotic technique, anastomotic location, conduit location, and conduit selection, and are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=see_link&amp;anchor=H1813059#H1813059\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\", section on 'Hand-sewn versus stapled anastomosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=see_link&amp;anchor=H1813131#H1813131\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\", section on 'Cervical versus thoracic anastomosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk factors for developing an anastomotic leak include ischemia (odds ratio [OR] 5.5, 95% CI 2.5-12.2), neoadjuvant therapy (OR 2.2, 1.1-4.5), and comorbid conditions (OR 2.1, 1.1-3.9) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/49\">",
"     49",
"    </a>",
"    ]. The location of an anastomosis (ie, cervical or thoracic) is likely a variable for anastomotic leak rates, but there are insufficient data from randomized trials to determine the superiority of one technique over another [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/7\">",
"     7",
"    </a>",
"    ]. The thoracic anastomosis, due to a shorter conduit length and less anastomotic tension, has the potential for less ischemia; however, the morbidity of pleural and mediastinal soilage is high.",
"   </p>",
"   <p>",
"    Cervical leaks, on the other hand, may be more frequent but appear to be better tolerated due to the anatomic confines of the neck and thoracic inlet that limits surrounding tissue contamination. In a meta-analysis of four randomized trials that included 267 patients, those undergoing a cervical anastomosis were significantly more likely to develop an anastomotic leakage compared with those undergoing a thoracic anastomosis (OR 3.43, 1.09-10.78) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/7\">",
"     7",
"    </a>",
"    ]. In addition, patients undergoing a cervical anastomosis had more recurrent nerve injuries (OR 7.14, 1.75-29.14), and there was no significant difference for rate of pulmonary complications, perioperative mortality, benign stricture formation, or tumor recurrence. Furthermore, a cervical anastomosis performed using a transhiatal approach can avoid the morbidity of thoracotomy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=see_link&amp;anchor=H1813131#H1813131\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\", section on 'Cervical versus thoracic anastomosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management of anastomotic leak involves several basic principles regardless of location.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assurance of adequate perfusion &ndash; The blood flow to the esophageal conduit is especially vulnerable to hypotension. All patients should have adequate hemodynamic monitoring with maintenance of euvolemia and avoidance of vasopressors if possible.",
"     </li>",
"     <li>",
"      Evaluation of primary source control &ndash; All leaks must be adequately drained whether by wound opening or percutaneous drainage. When an anastomotic leak is suspected, a CT scan can locate extra-anatomic collections.",
"     </li>",
"     <li>",
"      Cessation of contamination &ndash; A nasogastric tube is used to prevent continued contamination of surrounding structures while maintaining the patient on &ldquo;nothing by mouth&rdquo; (NPO, nil per os).",
"     </li>",
"     <li>",
"      Progressive conduit ischemia &ndash; In the clinical setting of progressive hypotension, oliguria and acidosis, progressive conduit ischemia and conduit necrosis can occur. If this is suspected, endoscopy can be useful to assess conduit viability.",
"     </li>",
"     <li>",
"      Antimicrobial agents &ndash; Intravenous antibiotics are administered at the time of clinical suspicion of a leak and antifungal medication should be considered for patients with chronic gastric acid reduction therapy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/20/329?source=see_link&amp;anchor=H359220294#H359220294\">",
"       \"Surgical management of esophageal perforation\", section on 'Initial management'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Broad spectrum intravenous antibiotics that provide coverage for aerobes and anaerobes are administered intravenously, such as",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"        ampicillin",
"       </a>",
"       /sulbactam",
"      </span>",
"      (3 grams every six hours), or",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?34/13/35030?source=see_link\">",
"        piperacillin",
"       </a>",
"       /tazobactam",
"      </span>",
"      (3.375 grams every six hours), or a carbapenem. In the setting of beta lactam hypersensitivity, use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      (900 mg every eight hours) plus a fluoroquinolone, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      (400 mg every 12 hours) is acceptable.",
"     </li>",
"     <li>",
"      Antifungal coverage (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/12/16586?source=see_link\">",
"       fluconazole",
"      </a>",
"      400 mg once a day) is administered in selected cases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In general, cervical anastomotic leaks can be managed with drainage of the neck wound at bedside with subsequent wet-to-dry dressing changes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/18\">",
"     18",
"    </a>",
"    ]. Thoracic anastomotic leaks are likely to require re-exploration for appropriate control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H178445010\">",
"    <span class=\"h2\">",
"     Anastomotic stricture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of anastomotic stricture ranges from 9 to 40 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/14,15,46,49,53-55\">",
"     14,15,46,49,53-55",
"    </a>",
"    ], and is often closely linked to conduit",
"    <span class=\"nowrap\">",
"     malperfusion/ischemia",
"    </span>",
"    and technique. In a retrospective review of 393 consecutive esophagectomy patients, patients with an anastomotic leak were significantly more likely to develop an anastomotic stricture compared with patients without a leak (47 versus 19 percent, OR 3.8, 1.9-7.6) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/49\">",
"     49",
"    </a>",
"    ]. Patients with an ischemic conduit were also more likely to develop a stricture (48 versus 5 percent, OR 4.4, 2.0-9.6). However, of those 80 patients who developed a stricture, 65 percent had no evidence of an anastomotic leak or conduit ischemia. Patients free of ischemia and leak who developed stricture were more likely to have undergone a gastric pull-up procedure compared with a colonic interposition graft (25 versus 7 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/49\">",
"     49",
"    </a>",
"    ]. No ischemic stricture occurred after six months.",
"   </p>",
"   <p>",
"    Anastomotic strictures can lead to obstruction, dysphagia, odynophagia, aspiration, and malnutrition (see",
"    <a class=\"local\" href=\"#H88997111\">",
"     'Dysphagia'",
"    </a>",
"    below). Patients with a postoperative stricture should undergo endoscopy and a biopsy to determine if recurrent disease is present. Endoscopic dilatation (ie, balloon or Savary dilators) is effective in relieving symptoms in 93 percent of patients with either a gastric or a colonic conduit not related to a local recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/49\">",
"     49",
"    </a>",
"    ]. Re-dilatation is performed for those who do not respond to the initial attempt. Endoscopic management of benign strictures is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/24/39305?source=see_link\">",
"     \"Management of benign esophageal strictures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cervical and thoracic strictures are managed similarly, using endoscopic guidance, generally with Savary dilators or balloon dilators. Dilation is performed as soon as the patient presents with dysphagia and is repeated as often as necessary to control symptoms. In the typical clinical setting, dilatation is used on average twice. Surgical revision of the anastomosis is rarely indicated and generally involves a resection and diversion procedure.",
"   </p>",
"   <p>",
"    In the clinical setting of locally recurrent esophageal disease, surgical resection should be considered in patients who are able to tolerate an additional surgical procedure. For a recurrent lesion confined to a small area, a local resection and reanastomosis can be performed; however, a completion esophagogastrectomy and colonic interposition are more often required [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/56\">",
"     56",
"    </a>",
"    ]. Chemotherapy and radiation therapy are also utilized in the management of patients with a local recurrence. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/25/30106?source=see_link\">",
"     \"Management of locally advanced unresectable esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92141803\">",
"    <span class=\"h2\">",
"     Conduit ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemia of the conduit (gastric and colonic) occurs in approximately 9 percent of patients undergoing an esophagectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/49\">",
"     49",
"    </a>",
"    ], but necessitates a surgical revision in only 1 to 2 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/2,21,49,57\">",
"     2,21,49,57",
"    </a>",
"    ]. In a retrospective review of 393 consecutive esophagectomy patients, the rate of ischemia identified by endoscopy following a gastric pull-up was similar to that of a colonic interposition graft (10.4 versus 7.4 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/49\">",
"     49",
"    </a>",
"    ]. Comorbid illness increases the risk of conduit ischemia twofold (OR 2.2, 1.1-4.3) and patients with conduit ischemia had a higher 30-day mortality rate compared with those without ischemia (13.9 versus 3.9 percent).",
"   </p>",
"   <p>",
"    Total conduit ischemia can present as a rapidly deteriorating course with evidence of septic shock (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=see_link\">",
"     \"Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis\"",
"    </a>",
"    ). Endoscopic evaluation should be performed to evaluate the viability of the neoesophageal mucosa. If the mucosa appears white, gray, or black, especially over significant surface are, surgical re-exploration should be performed to evaluate for full thickness necrosis. In this circumstance, the conduit must be removed and an esophagostomy must be constructed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92141810\">",
"    <span class=\"h2\">",
"     Functional conduit disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal digestive function is reported in &lt;20 percent of patients following esophagectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/55,58\">",
"     55,58",
"    </a>",
"    ]. Functional conduit disorders include dumping syndrome, postprandial hypoglycemia, delayed gastric emptying, dysphagia, and esophageal reflux. Dumping occurs in up to 50 percent of patients following esophagectomy, with 1 to 5 percent having disabling symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88997060\">",
"    <span class=\"h3\">",
"     Postgastrectomy syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients have early onset (within 10 to 30 minutes) postprandial symptoms (dumping syndrome), most likely due to rapid transit of hyperosmolar gastric contents into the small bowel. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/57/33688?source=see_link&amp;anchor=H10#H10\">",
"     \"Role of surgery in the management of peptic ulcer disease\", section on 'Postgastrectomy syndromes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Late onset postprandial symptoms (one to three hours) occur in 25 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/60\">",
"     60",
"    </a>",
"    ], and are attributed to hypoglycemia secondary to a profound insulin response to a carbohydrate challenge. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/11/3255?source=see_link\">",
"     \"Postprandial (reactive) hypoglycemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management generally begins with dietary alterations, including reduction of simple sugars; increased frequency and decreased size of meals; and fluid restriction around meals to slow gastric transit.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     Octreotide",
"    </a>",
"    may be considered in patients with refractory to dietary modification [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88997075\">",
"    <span class=\"h3\">",
"     Delayed gastric emptying",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delayed gastric emptying, or gastric outlet obstruction, occurs in up to 50 percent of patients following esophagectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/59\">",
"     59",
"    </a>",
"    ], secondary to truncal vagotomy performed during resection and anatomic compression inherent to the orthotopic route of restoration of gastrointestinal continuity. In clinical settings such as Barrett&rsquo;s syndrome and intramucosal carcinoma, vagal sparing procedures can be performed with the resultant reduction in the rate of postoperative dumping and weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/63\">",
"     63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/62/14312?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathogenesis of delayed gastric emptying\", section on 'Control of gut motor function'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=see_link&amp;anchor=H15#H15\">",
"     \"Management of Barrett's esophagus\", section on 'Esophagectomy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/60/20426?source=see_link&amp;anchor=H5#H5\">",
"     \"Management of superficial esophageal cancer\", section on 'Esophagectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of a gastric outlet procedure during the esophagectomy is generally accepted, although debated. Proponents of gastric outlet procedures (eg, pyloromyotomy, pyloroplasty) emphasize the low morbidity of the procedure and potential benefits with regard to early pulmonary complications. Opponents emphasize the long-term benefits of an intact pylorus, including diminished biliary reflux, diminished dumping, avoidance of complications at the site of the procedure and the ability to address gastric outlet issues endoscopically. More recently, botulinum toxin (Botox) has been injected into the pylorus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/64\">",
"     64",
"    </a>",
"    ] thus achieving a temporary gastric outlet procedure which may achieve the early benefits of a gastric outlet procedure while avoiding later complications. In this clinical setting, we generally perform a pyloroplasty for a durable resolution of symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88997111\">",
"    <span class=\"h3\">",
"     Dysphagia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysphagia occurs in up to 65 percent of patients following esophagectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/65\">",
"     65",
"    </a>",
"    ], with only 3 to 4 percent experiencing severe dysphagia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/59\">",
"     59",
"    </a>",
"    ]. The most common etiology is an anastomotic stricture, although other causes include conduit functional disorders, anatomic obstruction, and tumor recurrence.",
"   </p>",
"   <p>",
"    Symptoms of dysphagia from a stricture can be effectively managed by dilation. In a review of 27 patients with postoperative dysphagia following an esophagectomy with a gastric conduit and cervical anastomosis, most patients had dysphagia with each meal (63 percent), mild to moderate stricture diameter (93 percent, 5 to 12 mm), and no correlation between dysphagia frequency and stricture size [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/65\">",
"     65",
"    </a>",
"    ]. All patients experienced symptomatic improvement with subsequent endoscopic dilation, and 77 percent had sustainable relief of dysphagia following a median of two dilation sessions.",
"   </p>",
"   <p>",
"    Benign causes of dysphagia, such as pyloric stenosis, can be addressed endoscopically with balloon dilation or botox, depending on what prior pyloric procedures have been performed and if conduit",
"    <span class=\"nowrap\">",
"     malposition/redundancy",
"    </span>",
"    may require surgical revision. Malignant obstruction should be addressed as previously discussed. (See",
"    <a class=\"local\" href=\"#H178445010\">",
"     'Anastomotic stricture'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88997118\">",
"    <span class=\"h3\">",
"     Reflux",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acid reflux",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    duodenogastroesophageal reflux occurs in approximately 20 to 80 percent of all esophagectomy patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/54,55,66-68\">",
"     54,55,66-68",
"    </a>",
"    ]. Based upon a retrospective review of long-term functional outcomes following an esophagectomy, most patients have normal gastric function after three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/58\">",
"     58",
"    </a>",
"    ]. In a retrospective review of the literature, factors that contribute to postoperative reflux include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/66\">",
"     66",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Disruption or loss of normal antireflux mechanisms with gastric conduit (ie, lower esophageal sphincter, angle of His, diaphragmatic sling)",
"     </li>",
"     <li>",
"      Direct anastomosis with no sphincter-like mechanism to prevent reflux",
"     </li>",
"     <li>",
"      Positive intra-abdominal pressure promotes reflux proximally through the anastomosis",
"     </li>",
"     <li>",
"      Negative intrathoracic pressure",
"     </li>",
"     <li>",
"      Impaired gastric motility",
"     </li>",
"     <li>",
"      Impaired esophageal remnant motility, possibly related to denervation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment with proton pump inhibitors, motility agents, and endoscopic evaluation is appropriate in the symptomatic patient. Management of gastroesophageal reflux disease is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/53/42840?source=see_link\">",
"     \"Medical management of gastroesophageal reflux disease in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42905?source=see_link\">",
"     \"Surgical management of gastroesophageal reflux in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92141817\">",
"    <span class=\"h1\">",
"     DIAPHRAGMATIC HERNIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diaphragmatic hernias are an uncommon but challenging problem following procedures to restore gastrointestinal integrity. In a retrospective review of 2182 esophagectomy patients, the risk of a diaphragmatic hernia was less than 1 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/69\">",
"     69",
"    </a>",
"    ], with a higher rate when resections were performed using minimally invasive approaches compared with an open approach (2.8 versus 0.8 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diaphragmatic hernia repairs should be considered in all patients unless small and asymptomatic or in patients who are at prohibitive risk for surgical intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/69\">",
"     69",
"    </a>",
"    ]. Symptomatic hernias are associated with nausea, vomiting, progressive chest pain, and unexplained weight loss. In general, the repair is performed by laparotomy with reduction of hernia contents (eg, colon, small bowel), primary repair of the hernia defect, and avoiding injury to the vasculature of the neoesophagus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89118817\">",
"    <span class=\"h1\">",
"     CARDIOVASCULAR COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiovascular complications include a spectrum of events, such as atrial fibrillation, myocardial infarction, and venous thromboembolism, and are variably defined and reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9367772\">",
"    <span class=\"h2\">",
"     Atrial fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial fibrillation, reported to occur in approximately 20 percent of patients undergoing an esophagectomy, is a surrogate marker for surgical morbidity and mortality following major thoracic operations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. For example, a retrospective review of 921 patients undergoing an esophagectomy found that patients with postoperative atrial fibrillation had significantly higher rates of pulmonary complications, anastomotic leaks, and mortality rates compared with patients without atrial fibrillation (42 versus 17 percent, 6.9 versus 1.4 percent, and 23 versus 6 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/71\">",
"     71",
"    </a>",
"    ]. Patients undergoing major thoracic operations (including esophagectomy) with postoperative atrial fibrillation also had a significantly higher mortality rate and longer hospital mean length of stay compared with those patients without atrial fibrillation (7.5 versus 2.0 percent, and [mean &plusmn; standard deviation] 8.2 &plusmn; 11.0 versus 16.6 &plusmn; 18.6 days, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mediastinal node dissection, but not the type of esophagectomy procedure, is associated with an increased risk of postoperative atrial fibrillation. In a retrospective review of 324 esophagectomy patients, the incidence of atrial fibrillation for patients undergoing a transthoracic esophagectomy, transhiatal esophagectomy, and 3-field esophagectomy was 16.2, 18.6, and 16.7 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/72\">",
"     72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=see_link&amp;anchor=H7377436#H7377436\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\", section on 'Thoracic cancer resection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management of atrial fibrillation is typically done in consultation with a cardiologist and is discussed in separate topics. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/6/39016?source=see_link\">",
"     \"Management of new onset atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/28/20938?source=see_link\">",
"     \"Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Recommendations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/20/6473?source=see_link\">",
"     \"Overview of the acute management of tachyarrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9367779\">",
"    <span class=\"h2\">",
"     Myocardial infarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon a large prospective cohort study and retrospective reviews, the incidence of a postoperative myocardial infarction ranges from 1.1 to 3.8 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/2,3,26\">",
"     2,3,26",
"    </a>",
"    ]. Management of a postoperative myocardial infarction is typically done in consultation with a cardiologist and is discussed in separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/17/29975?source=see_link\">",
"     \"Perioperative myocardial infarction after noncardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9367786\">",
"    <span class=\"h2\">",
"     Venous thromboembolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of venous thromboembolism, including pulmonary embolus, is approximately 1.5 to 2.4 percent following an esophagectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/2,26\">",
"     2,26",
"    </a>",
"    ]. The management of postoperative deep vein thrombosis and pulmonary embolism are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link\">",
"     \"Treatment of lower extremity deep vein thrombosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/1/28697?source=see_link\">",
"     \"Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/59/43961?source=see_link\">",
"     \"Low molecular weight heparin for venous thromboembolic disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/58/19367?source=see_link\">",
"     \"Treatment of venous thromboembolism in patients with malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89118824\">",
"    <span class=\"h1\">",
"     RECURRENT LARYNGEAL NERVE INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent laryngeal nerve (RLN) injury may present as hoarseness, dyspnea,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    aspiration pneumonia (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/57/31642?source=see_link&amp;anchor=H31#H31\">",
"     \"Initial and reoperative thyroidectomy\", section on 'Recurrent laryngeal nerve injury'",
"    </a>",
"    ). Once RLN injury is suspected postoperatively, laryngoscopy and esophageal swallow evaluation should be promptly obtained.",
"   </p>",
"   <p>",
"    Management includes vocal cord injection for temporary medialization to enhance postoperative pulmonary management and prevent aspiration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/73\">",
"     73",
"    </a>",
"    ]. If the traumatized RLN is not severed, the patient may recover function and voice. A retrospective review of 51 patients with vocal cord paralysis following an esophagectomy found that 21 patients (41 percent) healed spontaneously within one year and four additional patients healed within two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/74\">",
"     74",
"    </a>",
"    ]. Patients with persistent vocal cord paralysis can develop severe hoarseness from inability to close the glottis during exertion, debilitation in performance status, aspiration pneumonia, and difficulty swallowing. If vocal cord paralysis persists, permanent vocal cord medialization should be performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89118831\">",
"    <span class=\"h1\">",
"     CHYLOTHORAX",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injury to the lymphatic system during esophagectomy can result in a clinically significant chyle leak. Rates of injury range from 0 to 8 percent and are associated with mortality rates as high as 50 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/75\">",
"     75",
"    </a>",
"    ]. The diagnosis of a chyle leak is based upon an increase in chest tube output with enteral alimentation and a change in nature of the output from serosanguineous to a milky appearance. Pleural fluid triglyceride level &gt;110",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or presence of chylomicrons is generally diagnostic of a chyle leak [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once diagnosis is confirmed, management includes elimination of enteral nutrition with consideration for parenteral nutrition support, close observation of chest tube output,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    , and fluid resuscitation. A short course of conservative management is warranted; however, if the chyle leak persists at a rate of &gt;10",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    for five days, patients most likely will fail conservative management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/77\">",
"     77",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/32/31241?source=see_link&amp;anchor=H1067463#H1067463\">",
"     \"Management of chylothorax\", section on 'Postoperative (surgical) chylothorax'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Early surgical intervention (within 14 days from diagnosis) is favored by many surgeons because of the high mortality rate associated with the resultant immunologic and nutritional depletion in an already compromised patient population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/78\">",
"     78",
"    </a>",
"    ]. The standard operative approach is a right thoracotomy with gentle retraction of the conduit and ligation of the thoracic duct. When available, a lymphangiogram should be performed prior to the operation to assess for a possible intra-abdominal or aberrant thoracic duct anatomy that would not be accessible using a right thoracotomy.",
"   </p>",
"   <p>",
"    Attempts can be made to identify the source of the leak by administering 25",
"    <span class=\"nowrap\">",
"     cc/hour",
"    </span>",
"    of cream or vegetable oil enterally for six hours prior to the operative procedure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/32/31241?source=see_link&amp;anchor=H1067386#H1067386\">",
"     \"Management of chylothorax\", section on 'Dietary control measures'",
"    </a>",
"    .) If the site of the leak is identified, the duct should be ligated proximally and distally, using ties or clips. If the site of the leak is not identified, ligation of all tissue between the spine and the aorta is performed as caudal as possible in the right hemithorax [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/79\">",
"     79",
"    </a>",
"    ]. The azygos vein can be ligated en bloc or preserved, based upon surgeon preference. Pleurodesis may also be entertained at this time to prevent effusion recurrence. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/32/31241?source=see_link&amp;anchor=H1067400#H1067400\">",
"     \"Management of chylothorax\", section on 'Pleurodesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An alternative to the surgical approach, postoperative lymphangiogram with percutaneous embolization or disruption of the thoracic duct can yield excellent success rates, but is highly dependent on the experience of the interventionalist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/29/43481/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89118874\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An esophagectomy is a complex procedure with a high rate of complications. (See",
"      <a class=\"local\" href=\"#H7783803\">",
"       'Morbidity and mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postoperative pulmonary complications, such as pneumonia, acute exacerbation of chronic obstructive pulmonary disease, bronchospasm, acute respiratory distress syndrome, and ventilator dependency, are the most frequent complications following esophagectomy, occurring in approximately 16 to 67 percent of all patients. (See",
"      <a class=\"local\" href=\"#H89118810\">",
"       'Pulmonary complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Atrial fibrillation, reported to occur in approximately 20 percent of patients undergoing an esophagectomy, is a surrogate marker for surgical morbidity and mortality following major thoracic operations. (See",
"      <a class=\"local\" href=\"#H9367772\">",
"       'Atrial fibrillation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An anastomotic leak is controlled by drainage, and the patient is treated with broad spectrum antibiotics and observed for evidence of progressive infection or conduit ischemia. Patients with a thoracic anastomosis are likely to require re-exploration for appropriate control of the leak. Cervical anastomotic leaks can be generally managed with drainage of the neck wound without operative intervention. (See",
"      <a class=\"local\" href=\"#H92141770\">",
"       'Anastomotic leak'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An endoscopy, biopsy of the stricture, and dilation at the onset of symptoms is performed for patients with a symptomatic anastomotic stricture (such as dysphagia, odynophagia). (See",
"      <a class=\"local\" href=\"#H178445010\">",
"       'Anastomotic stricture'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H88997111\">",
"       'Dysphagia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postgastrectomy syndrome occurs in the majority of patients undergoing an esophagectomy and is initially managed with dietary alterations, such as restriction of simple sugars and increased frequency and decreased size of meals.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"       Octreotide",
"      </a>",
"      can be considered in patients refractory to dietary modification. (See",
"      <a class=\"local\" href=\"#H92141810\">",
"       'Functional conduit disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If a recurrent laryngeal nerve (RLN) injury is suspected postoperatively, based upon hoarseness and a weak, breathy cough, laryngoscopy and esophageal swallow evaluation should be promptly obtained. A vocal cord injection is used to manage symptomatic patients with a recurrent laryngeal nerve injury. If vocal cord paralysis persists, permanent vocal cord medialization can be performed. (See",
"      <a class=\"local\" href=\"#H89118824\">",
"       'Recurrent laryngeal nerve injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Conservative management with dietary modifications is initially attempted for patients with a chylothorax. If this fails, we ligate the thoracic duct proximally and distally to the leak with sutures. Thoracic duct embolization is an alternative to operative repair if a skilled interventionalist is available. (See",
"      <a class=\"local\" href=\"#H89118831\">",
"       'Chylothorax'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/1\">",
"      Metzger R, Bollschweiler E, Vallb&ouml;hmer D, et al. High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus 2004; 17:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/2\">",
"      Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003; 75:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/3\">",
"      Seely AJ, Ivanovic J, Threader J, et al. Systematic classification of morbidity and mortality after thoracic surgery. Ann Thorac Surg 2010; 90:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/4\">",
"      Shen KR, Harrison-Phipps KM, Cassivi SD, et al. Esophagectomy after anti-reflux surgery. J Thorac Cardiovasc Surg 2010; 139:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/5\">",
"      Blencowe NS, Strong S, McNair AG, et al. Reporting of short-term clinical outcomes after esophagectomy: a systematic review. Ann Surg 2012; 255:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/6\">",
"      Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001; 72:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/7\">",
"      Biere SS, Maas KW, Cuesta MA, van der Peet DL. Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis. Dig Surg 2011; 28:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/8\">",
"      Ruteg&aring;rd M, Lagergren P, Rouvelas I, et al. Surgical complications and long-term survival after esophagectomy for cancer in a nationwide Swedish cohort study. Eur J Surg Oncol 2012; 38:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/9\">",
"      Morita M, Nakanoko T, Fujinaka Y, et al. In-hospital mortality after a surgical resection for esophageal cancer: analyses of the associated factors and historical changes. Ann Surg Oncol 2011; 18:1757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/10\">",
"      Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/11\">",
"      Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000; 119:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/12\">",
"      Lagarde SM, Reitsma JB, Maris AK, et al. Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram. Ann Thorac Surg 2008; 85:1938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/13\">",
"      Connors RC, Reuben BC, Neumayer LA, Bull DA. Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg 2007; 205:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/14\">",
"      Saluja SS, Ray S, Pal S, et al. Randomized trial comparing side-to-side stapled and hand-sewn esophagogastric anastomosis in neck. J Gastrointest Surg 2012; 16:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/15\">",
"      Law S, Fok M, Chu KM, Wong J. Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: a prospective randomized controlled trial. Ann Surg 1997; 226:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/16\">",
"      Inoue J, Ono R, Makiura D, et al. Prevention of postoperative pulmonary complications through intensive preoperative respiratory rehabilitation in patients with esophageal cancer. Dis Esophagus 2013; 26:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/17\">",
"      Schieman C, Wigle DA, Deschamps C, et al. Patterns of operative mortality following esophagectomy. Dis Esophagus 2012; 25:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/18\">",
"      Swanson SJ, Batirel HF, Bueno R, et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg 2001; 72:1918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/19\">",
"      Markar SR, Karthikesalingam A, Thrumurthy S, Low DE. Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000-2011. J Gastrointest Surg 2012; 16:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/20\">",
"      Kuo EY, Chang Y, Wright CD. Impact of hospital volume on clinical and economic outcomes for esophagectomy. Ann Thorac Surg 2001; 72:1118.",
"     </a>",
"    </li>",
"    <li>",
"     Orringer MB, Marshall B, Chang AC, et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg. Sep 2007; 246:363.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/22\">",
"      Rodgers M, Jobe BA, O'Rourke RW, et al. Case volume as a predictor of inpatient mortality after esophagectomy. Arch Surg 2007; 142:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/23\">",
"      Varghese TK Jr, Wood DE, Farjah F, et al. Variation in esophagectomy outcomes in hospitals meeting Leapfrog volume outcome standards. Ann Thorac Surg 2011; 91:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/24\">",
"      Kayani B, Okabayashi K, Ashrafian H, et al. Does obesity affect outcomes in patients undergoing esophagectomy for cancer? A meta-analysis. World J Surg 2012; 36:1785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/25\">",
"      Koppert LB, Lemmens VE, Coebergh JW, et al. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer. Br J Surg 2012; 99:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/26\">",
"      Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg 2004; 78:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/27\">",
"      Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/28\">",
"      van Lanschot JJ, Hulscher JB, Buskens CJ, et al. Hospital volume and hospital mortality for esophagectomy. Cancer 2001; 91:1574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/29\">",
"      Dimick JB, Cattaneo SM, Lipsett PA, et al. Hospital volume is related to clinical and economic outcomes of esophageal resection in Maryland. Ann Thorac Surg 2001; 72:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/30\">",
"      Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998; 280:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/31\">",
"      Gordon TA, Bowman HM, Bass EB, et al. Complex gastrointestinal surgery: impact of provider experience on clinical and economic outcomes. J Am Coll Surg 1999; 189:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/32\">",
"      Verhoef C, van de Weyer R, Schaapveld M, et al. Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists. Ann Surg Oncol 2007; 14:1678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/33\">",
"      Reavis KM, Smith BR, Hinojosa MW, Nguyen NT. Outcomes of esophagectomy at academic centers: an association between volume and outcome. Am Surg 2008; 74:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/34\">",
"      Derogar M, Sadr-Azodi O, Johar A, et al. Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study. J Clin Oncol 2013; 31:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/35\">",
"      Meguid RA, Weiss ES, Chang DC, et al. The effect of volume on esophageal cancer resections: what constitutes acceptable resection volumes for centers of excellence? J Thorac Cardiovasc Surg 2009; 137:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/36\">",
"      Gillison EW, Powell J, McConkey CC, Spychal RT. Surgical workload and outcome after resection for carcinoma of the oesophagus and cardia. Br J Surg 2002; 89:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/37\">",
"      Rouvelas I, Lindblad M, Zeng W, et al. Impact of hospital volume on long-term survival after esophageal cancer surgery. Arch Surg 2007; 142:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/38\">",
"      Avendano CE, Flume PA, Silvestri GA, et al. Pulmonary complications after esophagectomy. Ann Thorac Surg 2002; 73:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/39\">",
"      Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347:1662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/40\">",
"      Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 2012; 379:1887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/41\">",
"      Briez N, Piessen G, Torres F, et al. Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications. Br J Surg 2012; 99:1547.",
"     </a>",
"    </li>",
"    <li>",
"     Mistry RC, Vijayabhaskar R, Karimundackal G, Jiwnani S, Pramesh CS. Effect of short-term vs prolonged nasogastric decompression on major postesophagectomy complications. Arch Surg 2012, 147:747.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/43\">",
"      Boyle NH, Pearce A, Hunter D, et al. Intraoperative scanning laser Doppler flowmetry in the assessment of gastric tube perfusion during esophageal resection. J Am Coll Surg 1999; 188:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/44\">",
"      Beitler AL, Urschel JD. Comparison of stapled and hand-sewn esophagogastric anastomoses. Am J Surg 1998; 175:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/45\">",
"      Collard JM, Romagnoli R, Goncette L, et al. Terminalized semimechanical side-to-side suture technique for cervical esophagogastrostomy. Ann Thorac Surg 1998; 65:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/46\">",
"      Orringer MB, Marshall B, Iannettoni MD. Eliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis. J Thorac Cardiovasc Surg 2000; 119:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/47\">",
"      Kim RH, Takabe K. Methods of esophagogastric anastomoses following esophagectomy for cancer: A systematic review. J Surg Oncol 2010; 101:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/48\">",
"      Hsu HH, Chen JS, Huang PM, et al. Comparison of manual and mechanical cervical esophagogastric anastomosis after esophageal resection for squamous cell carcinoma: a prospective randomized controlled trial. Eur J Cardiothorac Surg 2004; 25:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/49\">",
"      Briel JW, Tamhankar AP, Hagen JA, et al. Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg 2004; 198:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/50\">",
"      Sepesi B, Swisher SG, Walsh GL, et al. Omental reinforcement of the thoracic esophagogastric anastomosis: an analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg 2012; 144:1146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/51\">",
"      Price TN, Nichols FC, Harmsen WS, et al. A comprehensive review of anastomotic technique in 432 esophagectomies. Ann Thorac Surg 2013; 95:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/52\">",
"      Baba M, Aikou T, Natsugoe S, et al. Appraisal of ten-year survival following esophagectomy for carcinoma of the esophagus with emphasis on quality of life. World J Surg 1997; 21:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/53\">",
"      Chang AC, Ji H, Birkmeyer NJ, et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 2008; 85:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/54\">",
"      De Boer AG, Genovesi PI, Sprangers MA, et al. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg 2000; 87:1716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/55\">",
"      McLarty AJ, Deschamps C, Trastek VF, et al. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997; 63:1568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/56\">",
"      Schipper PH, Cassivi SD, Deschamps C, et al. Locally recurrent esophageal carcinoma: when is re-resection indicated? Ann Thorac Surg 2005; 80:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/57\">",
"      Griffin SM, Shaw IH, Dresner SM. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management. J Am Coll Surg 2002; 194:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/58\">",
"      Headrick JR, Nichols FC 3rd, Miller DL, et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 2002; 73:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/59\">",
"      Donington JS. Functional conduit disorders after esophagectomy. Thorac Surg Clin 2006; 16:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/60\">",
"      Burt M, Scott A, Williard WC, et al. Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: a randomized clinical trial. J Thorac Cardiovasc Surg 1996; 111:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/61\">",
"      Penning C, Vecht J, Masclee AA. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome. Aliment Pharmacol Ther 2005; 22:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/62\">",
"      Geer RJ, Richards WO, O'Dorisio TM, et al. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 1990; 212:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/63\">",
"      Peyre CG, DeMeester SR, Rizzetto C, et al. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia. Ann Surg 2007; 246:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/64\">",
"      Martin JT, Federico JA, McKelvey AA, et al. Prevention of delayed gastric emptying after esophagectomy: a single center's experience with botulinum toxin. Ann Thorac Surg 2009; 87:1708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/65\">",
"      Williams VA, Watson TJ, Zhovtis S, et al. Endoscopic and symptomatic assessment of anastomotic strictures following esophagectomy and cervical esophagogastrostomy. Surg Endosc 2008; 22:1470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/66\">",
"      Aly A, Jamieson GG. Reflux after oesophagectomy. Br J Surg 2004; 91:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/67\">",
"      Yuasa N, Sasaki E, Ikeyama T, et al. Acid and duodenogastroesophageal reflux after esophagectomy with gastric tube reconstruction. Am J Gastroenterol 2005; 100:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/68\">",
"      Dresner SM, Griffin SM, Wayman J, et al. Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia. Br J Surg 2003; 90:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/69\">",
"      Price TN, Allen MS, Nichols FC 3rd, et al. Hiatal hernia after esophagectomy: analysis of 2,182 esophagectomies from a single institution. Ann Thorac Surg 2011; 92:2041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/70\">",
"      Kent MS, Luketich JD, Tsai W, et al. Revisional surgery after esophagectomy: an analysis of 43 patients. Ann Thorac Surg 2008; 86:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/71\">",
"      Murthy SC, Law S, Whooley BP, et al. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 2003; 126:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/72\">",
"      Vaporciyan AA, Correa AM, Rice DC, et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 2004; 127:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/73\">",
"      Wright CD, Zeitels SM. Recurrent laryngeal nerve injuries after esophagectomy. Thorac Surg Clin 2006; 16:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/74\">",
"      Baba M, Natsugoe S, Shimada M, et al. Does hoarseness of voice from recurrent nerve paralysis after esophagectomy for carcinoma influence patient quality of life? J Am Coll Surg 1999; 188:231.",
"     </a>",
"    </li>",
"    <li>",
"     &mdash; Bolger C, Walsh TN, Tanner WA, et al. Chylothorax after oesophagectomy. The British journal of surgery. May 1991;78(5):587-588.",
"    </li>",
"    <li>",
"     &mdash; Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clinic proceedings. Mayo Clinic. Nov 1980;55(11):700-704.",
"    </li>",
"    <li>",
"     &mdash; Dugue L, Sauvanet A, Farges O, Goharin A, Le Mee J, Belghiti J. Output of chyle as an indicator of treatment for chylothorax complicating oesophagectomy. Br J Surg. Aug 1998;85(8):1147-1149.",
"    </li>",
"    <li>",
"     &mdash; Merigliano S, Molena D, Ruol A, et al. Chylothorax complicating esophagectomy for cancer: a plea for early thoracic duct ligation. J Thorac Cardiovasc Surg. Mar 2000;119(3):453-457.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/79\">",
"      Merigliano S, Molena D, Ruol A, et al. Chylothorax complicating esophagectomy for cancer: a plea for early thoracic duct ligation. J Thorac Cardiovasc Surg 2000; 119:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/80\">",
"      Boffa DJ, Sands MJ, Rice TW, et al. A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg 2008; 33:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/29/43481/abstract/81\">",
"      Cope C, Salem R, Kaiser LR. Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J Vasc Interv Radiol 1999; 10:1248.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15058 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-199.231.185.123-EFBF5593C3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43481=[""].join("\n");
var outline_f42_29_43481=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H89118874\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89118788\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7783803\">",
"      MORBIDITY AND MORTALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8261725\">",
"      Overall morbidity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8263278\">",
"      Overall mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H178439131\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H178444755\">",
"      - Comorbid illnesses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H178444762\">",
"      - Increasing age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H86572444\">",
"      - Intraoperative variables",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H178436712\">",
"      - Hospital volume",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89118810\">",
"      PULMONARY COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H92141763\">",
"      CONDUIT-RELATED DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H92141770\">",
"      Anastomotic leak",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H178445010\">",
"      Anastomotic stricture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H92141803\">",
"      Conduit ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H92141810\">",
"      Functional conduit disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H88997060\">",
"      - Postgastrectomy syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H88997075\">",
"      - Delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H88997111\">",
"      - Dysphagia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H88997118\">",
"      - Reflux",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H92141817\">",
"      DIAPHRAGMATIC HERNIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89118817\">",
"      CARDIOVASCULAR COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9367772\">",
"      Atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9367779\">",
"      Myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9367786\">",
"      Venous thromboembolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89118824\">",
"      RECURRENT LARYNGEAL NERVE INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89118831\">",
"      CHYLOTHORAX",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89118874\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/28/20938?source=related_link\">",
"      Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/1/28697?source=related_link\">",
"      Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/57/31642?source=related_link\">",
"      Initial and reoperative thyroidectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/59/43961?source=related_link\">",
"      Low molecular weight heparin for venous thromboembolic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=related_link\">",
"      Management of Barrett's esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/24/39305?source=related_link\">",
"      Management of benign esophageal strictures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/32/31241?source=related_link\">",
"      Management of chylothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/25/30106?source=related_link\">",
"      Management of locally advanced unresectable esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/6/39016?source=related_link\">",
"      Management of new onset atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/60/20426?source=related_link\">",
"      Management of superficial esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/53/42840?source=related_link\">",
"      Medical management of gastroesophageal reflux disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/16/9480?source=related_link\">",
"      Nasogastric and nasoenteric tubes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/20/6473?source=related_link\">",
"      Overview of the acute management of tachyarrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/10/11434?source=related_link\">",
"      Overview of the management of postoperative pulmonary complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/62/14312?source=related_link\">",
"      Pathogenesis of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/17/29975?source=related_link\">",
"      Perioperative myocardial infarction after noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/11/3255?source=related_link\">",
"      Postprandial (reactive) hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/57/33688?source=related_link\">",
"      Role of surgery in the management of peptic ulcer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=related_link\">",
"      Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/51/13113?source=related_link\">",
"      Strategies to reduce postoperative pulmonary complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/20/329?source=related_link\">",
"      Surgical management of esophageal perforation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42905?source=related_link\">",
"      Surgical management of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/30/34282?source=related_link\">",
"      Surgical oncologic principles for management of resectable esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=related_link\">",
"      Treatment of lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/58/19367?source=related_link\">",
"      Treatment of venous thromboembolism in patients with malignancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_29_43482="Churg Strauss granuloma";
var content_f42_29_43482=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F50143%7ERHEUM%2F57180%7EPULM%2F82366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F50143%7ERHEUM%2F57180%7EPULM%2F82366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph shows the palisading granuloma of&nbsp;eosinophilic granulomatosis with polyangiitis (Churg-Strauss) characterized by an area of necrobiosis (arrow) permeated by disintegrating neutrophils and palisaded by a histiocytic infiltrate. There may or may not be an accompanying vasculitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cynthia Magro, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Histopathology of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 235px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Small artery in a patient with&nbsp;eosinophilic granulomatosis with polyangiitis (Churg-Strauss) showing intimal fibrinoid necrosis and mural infiltration by histiocytes consistent with a necrotizing granulomatous vasculitis. There is marked extravascular eosinophilia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 354px; height: 245px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view of a lung biopsy from a patient with eosinophilic granulomatosis with polyangiitis (Churg-Strauss) showing well-established, necrotizing and occlusing arterial lesions with obliteration of the arterial lumen. Dilatation of lymphatic channels in the arterial adventitia contributes significantly to the marked size discrepancy between the artery and its adjacent bronchiole. Other regions of the lung reveal marked intraalveolar eosinophilic infiltration in the parenchyma (Hematoxylin and eosin, x 10).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Talmadge E King, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43482=[""].join("\n");
var outline_f42_29_43482=null;
var title_f42_29_43483="Characteristics of major noncardiac causes of chest pain";
var content_f42_29_43483=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77753&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77753&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics of major noncardiac causes of chest pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Condition",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration of pain",
"       </td>",
"       <td class=\"subtitle1\">",
"        Character of pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastroesophageal reflux",
"       </td>",
"       <td>",
"        5 to 60 min",
"       </td>",
"       <td>",
"        Visceral, substernal, worse with recumbency, no radiation,",
"relief with food, antacids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Esophageal spasm",
"       </td>",
"       <td>",
"        5 to 60 min",
"       </td>",
"       <td>",
"        Visceral, spontaneous, substernal, associated with cold",
"liquids, relief with nitroglycerin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Peptic ulcer",
"       </td>",
"       <td>",
"        Hours",
"       </td>",
"       <td>",
"        Visceral, burning, epigastric, relief with food, antacids,",
"normal ECG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Biliary disease",
"       </td>",
"       <td>",
"        Hours",
"       </td>",
"       <td>",
"        Visceral, epigastric, interscapular colic, occurs after meals",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cervical disc",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"       <td>",
"        Superficial, positional, arm, neck",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Musculoskeletal",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"       <td>",
"        Superficial, positional, worse with movement, local tenderness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperventilation",
"       </td>",
"       <td>",
"        2 to 3 min",
"       </td>",
"       <td>",
"        Visceral, substernal, tachypneic, anxious",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thyroiditis",
"       </td>",
"       <td>",
"        Persistent",
"       </td>",
"       <td>",
"        Aggravated by swallowing, neck, throat tenderness",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Excludes pain above the neck or below the umbilicus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43483=[""].join("\n");
var outline_f42_29_43483=null;
var title_f42_29_43484="Features antibody classes";
var content_f42_29_43484=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F74659&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F74659&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics of antibody (immunoglobulin) classes and subclasses",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Class",
"       </td>",
"       <td class=\"subtitle1\">",
"        Subclass",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mw, kd",
"       </td>",
"       <td class=\"subtitle1\">",
"        No. CH domains",
"       </td>",
"       <td class=\"subtitle1\">",
"        Serum concentration, gm/L",
"       </td>",
"       <td class=\"subtitle1\">",
"        Serum half-life, days",
"       </td>",
"       <td class=\"subtitle1\">",
"        Properties",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgG",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        150",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        5 - 15",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        Complement fixation, opsonization, placental transfer. Predominant in secondary response.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        IgG1",
"       </td>",
"       <td>",
"        (monomer)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3 - 10",
"       </td>",
"       <td>",
"        23",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgG2",
"       </td>",
"       <td>",
"        (monomer)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1 - 3.5",
"       </td>",
"       <td>",
"        23",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgG3",
"       </td>",
"       <td>",
"        (monomer)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        0.3 - 1",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgG4",
"       </td>",
"       <td>",
"        (monomer)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        0.2 - 0.5",
"       </td>",
"       <td>",
"        23",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgM",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        950 (pentamer)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        0.5 - 4",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        Complement fixation, predominant in primary response, B cell receptor.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgA",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        400",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        0.5 - 3.5",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Predominant in secretions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        IgA1",
"       </td>",
"       <td>",
"        (dimer)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgA2",
"       </td>",
"       <td>",
"        (dimer)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgD",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        170 (monomer)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        B cell receptor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgE",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        190 (monomer)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        0 - 250 ug/L",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        Immediate hypersensitivity",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43484=[""].join("\n");
var outline_f42_29_43484=null;
var title_f42_29_43485="Maternal complications of diabetic nephropathy in pregnancy";
var content_f42_29_43485=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F73010&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F73010&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Maternal complications in pregnancies complicated by diabetic nephropathy (2001 to 2012)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 415px; height: 344px; background-image: url(data:image/gif;base64,R0lGODlhnwFYAcQAAP///wAz/wAAAN3d3WZmZpmZmYiIiO7u7iIiIjMzM0RERBEREbu7u8zMzKqqqnd3d1VVVQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAACfAVgBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ1PDwICCAwiBqEJA56qqzUFC6kPCwANAg0AEBCsurssBQgHAA4IAAYKIgyyvMrLIwQCBAm2BAQiAwLAzNmsDAgDBQm509XXJKHm56Ha6o8QBuMDxSIOyS0C6/eLD93ECwe0trhe2MNH0NABCKFGlTqVysXAghA7PYxIEdPEihgnXczI0dHGjiATfQxJktDIkij//5xkga6ly5cwY8o8l7KmjJUrBATYybOnz59AgwodyhOnzaMjjKbQSbSp06dAlSK1KfUEU6hYswatOhUl1xJXtYrV+rVryLJJx6rNitYsx7YAwq6dKxSu24pw5dLd29Pu3Yh5+Qr26fdvwcCDExc2jA9xYsF5Z0qeTBkd4zmOH+/NrHnu4stZOHdWK3q02M+gr5Q2zbaGXtatU79ZDfsp7dpNUcumchv30N6+t+52Azz4z+LG+w5vgzz5zubOdS+HAj15dePSpzu5Hpy77+zamXjHPb42+PBKysNWz/o8eiTsTccf7f69kfmd8Wuub5+I/sf/KdZfGQEOViBkA5JxIP9fC26W4BgN0hWhZw+KMeFaF5JWYRgZjtXhaRuC8SFZrjkHFX8h8jBibDO8ZmJUKXqxIlYznhhjFzXaVuKLud3IRY5OAdmjj1oISZSRvxFZ5I48JkmDi00WpWRoTEYJ45NW1jUlFkhqiWWWV25ZRZfCfQkmYWJaQWaYN515XJpjVulmAGu+CecUdaJp5px03omnnG7mqZyfUQgq5Z5zokhoPYCeaehzi1LXKJiP9hnpdpNmWamily6VqZWbdtpEqIgGKqp4n0ZJ6qlJrNomn5Cy2mqqTboqaxG2wgAlqLe2cFAo7hDDkEC08phrryYkoAA2s9RySy4OFfvisciOME//CfEAgAyxpToqrYmcPqiPOQUAIA4A1jCb07fRsWuda5XFKy9MBEEjQgHXnJtuOTG5i52/3QEcMD4GQBsXA9leG223lApMnsMP48OAAKQY0M8/z3LbIqyxbsxxpZYSnBApwgqAisavwkptPRx3/NfKLLUMcri7wJyTzBCbd5nNKuyqas7r7Qy0fEPTV7TRjPG8FM4MN5z00ftBDaDUUz/dNK9X/5y11oYpjYLPtVItoNUeqyw2gluHTXbKfHptVcshv3w2g3M7mLaxQt8Nbt0S8t332jGAjbfe7RJeeNd+Y5i4hoa/C7iuTJfd9uKMI974wJInSrmHeWdu6uXfbQ7i/+MCRc625qCHTrpDpgfeOuSvm+W2CYJPKzqJq7P88e008t577jHvnrrOwxNvuefeFt+e7zYCf7PwyDsdvfRyK0+09UhPr2nnp3+uPdfde1/992qTP7j5548fPvWuQ78++27NDlbsrNMfSQMQJMCAAg8sIX859gue+ygxgAWEwgEGGEZ6mBckBg4Jfba7RCzw5QAHkGNW2MuPA4+0QQ5KMAEHEAACLwifDnoJgod73/YugS+EKGABxlhgBqM2w6qhMIWVcEYoFmALGd7wXzUc2w+BiIkCPMAADfGhCsHXPrMFUYiWOIAUp+g/E5ZpiKrDYhYrYUF0LAuDWjTeEss3Rv8yUqKLXgRjGSMYxqA90UCYsOAUEVAMEuLKimxq4uTeiDZLgKIhCUgAKNTlHzzaqY3L4yPdLmEKBDzAhYMsoSL/hsjrVdKSlkiAORbggHMd4X9pGSDsREkJAxwxiWrUI+ouqcFJUtISDniALI9YRVcqzpaVWyMbK0GLcySglqykYTBtqMu9MVIAChDAAxRADSWqUnzPTN4wiUmJB+ivFg6IYSpHucdpwhGXuQzcvMY5ziNYM4S4sON9DKknb/axmDjk5iqJYEH8hUKbknTnIvVpN372E55ELAIwDmAAAxByneAcnT8plFCFAhRzRGDAL++Fz0+yc1ALvWVGNfrQLQr/4QBylCK+DlrIhrKooxHbaDjlCU0ghLAl9MgnSsUYTfiVLoDPc+IQXnqOBQRrmzfV6UzdqFLOmfR3RDiARKmIqqM2r6i4g2pUh5rII0yRpHd0qo602kCudlWqSE1qMs0xUaDWT6g1XSFYw5pWrBXBFL6UgSkaAteTLWytW8XrV6laVb5mjwimYABTYTAPAaQCYwG5q19bqdcHLpaxj6WmEArYgMG6gBYWTEW2tqXYtjKRpdKMrGSD2k16oqOsLBgAAhxgjVToS52e8qoHGztb0ULRs2YUAhpP8YIEuKO15mrmvpLSL9k6ibbHte03kXtCgV5VV+goQMJiui7jNhe3/+nDbnZBa9Mg4E9//JMBcBFrMJZc9FDMvaJy36ldYxahgAdMoHgNuxCTobK66c0jd9W63n3295VDmKAI5ejM/br1vwzNr35JO88Ag1CEpsCqEEApgtq5F8EJxvBKg9BCZMIQmBo2qoLbGWIRl3iqRNChAHgI4vbGk8EthXGMz1raIhgRiU0dMUZPfFIXv5jGDR6CA0jG2hYb+LMy7q7uSAnkGf8AX8FSAGotal31+jigV8bykXMbhEgCwMsyzbJHt7zdJCtZgDUWAih6iBAJB4HCccFpz+AGZxlMzJEuNLKZDyzmlPK4x2TeZYo32UOzLjnNe0Zyk52M5iAHAaSmxP+xnhd95pwimtKVnjOTfzAxBzwBzhb+8aEvPWpG+yABBbBsmAN94T7TlNWthrXjirBbk0261KF1NVH/zFZZazkItZ4yQnWMXl7n1djH1nVfk/rcWzfa1JpGq69/jWk+D+G7++tfgRPN5WorGte5nvaYgwBfCCvQ0M8ON7fL7O1vpzvTOxBwBWFbUmK7TNmYxHe+xe1nB4dwhG4GAqjlvDSCf83gOejwCys6bGQ7Vt+QhXjE+f1qIaiYxdtuN7vBzV+JC9PhtbXxKXMM8uR6/LYUr7jGBS0EU3oaU1Ve8Mpjve6Nv7vjQRjrM2Bu77idfLklN3nKlw0EWggSAfQl+c//2Tv0fdec5U8XNQ8sWC4Kjuq89276X5fO9KjPWrciBGnYla71iXud2hzH+dkhCmyXCDurPR84wmk39xrUmrcZT7u7Le3omdPc71//6FWlSPa1jxvwaL+52hHPdjrIXdqGP7zeux2Hx5Na8daOvMorj3Wfl/3jXPdv6AHs+M5b/vJ8hzZzTM/6mMt88jafTevj3nnPa37XdTi96g9edwBuGg66VzfjG397omNm9kG38udBv3yUH9/1JB59hqU//eYDPffIp/6Ghy95zFMe+Nm3fte532/xi7700N+x9k28fvab/5/YT3+x24/i98Pf/tV/Pu3ln/XiG5/8uId++zeA/8mnfP63dQJYgIekgNGHf/kHgP/HefxnexDodBVogbAHdXIQfPDGe7+XesIngQRIf4B2gAhogsynfwyofg64fRmogS8odbI3gRzYgW/zgcQRfig4Whd4gj2Yghuogz/IgzEog9GGejlIg0JYhIHXgu6ngiTYazvofENIhN4Xe0k4gk7oUFEohVV4fQnYhcm2hfU3hVTIhMRnBQ2gSSbTQ3V1Xz2zhFcIg3NIhyBog05QABAADMrSLABRXvi1gvNHhiX4hWBohuOXBQZADZtFXXGohJDYcxSIht1nBQchAq8VcEkhh3e4eJRYiUfYd1iwh5goXHYkE5wYirt3gzhYcP+QdwUDYFfEEEMKwyiRKIj9Z4iJWIdGGAXIUGh+mDGdRYhe+Imbx4u96IFIGAVwZQ6aNSzDiIjnJ433R43VqIvXKIK4OInImHid6IndmIbaKIZ7RY4PR4zFGI6guHq3aI4hh45PtY00Uyip6IrLqIz3yIr5qAY1mHnYmI3qWH5QCI/lSJDnaI2kh5AcFX9aqJAuGJAC+Y8POI4G+Y4O+YQSOZEQGYADeZFcWJFC55EfKZKFSJEkmY7fuHequIp014ps0I8qaY/7OD8uuQYw+X0pGZP4yJJpcJNYKJOiuJERCH7tCJLXZZRHeZLxyJDyWI87yZO+94ommZEPmZM/+ZT/ISiUGEiUDUmVGGmMx2iVdpiFTVmUSrmUSPl6XFmWXQmWHOmVIxmEZgmXZUiXdemWWzmDbamVPoiXebmSeNiTTqmPQSmWYwmUWamXbLmY7miRdomSZNmYSfmYaHmWY2iZBymXe2mYyUiYhQmY4KiYkmmAlHmZpWmafml2msmYabmAo0maqQmEUxmbVsiZTYiZmUmbZ7iWr+mardmAuOmYunmIq9mbwHmaucmXfamcssmbv8mCwTmZw0mc0zmNxfmcgxidsMmczWmb3hiZ2JmL1QmQ3vmdiBmYaOCTh4mV6BlKUumc2qmW5bmO7BmaoOmPs8mduzmfETme5HmfOmmT/4PZku/Jn/2pn9QJn8gpnAi6iwYalgCKk+AZn75Jocfpnwm5oCF5nRYKnRoqnQ3qoBF6lQI6lxi6kOEpniH6n+y4mSO6np4Jle45k+k5oDRZoC8KowRKo2egnn93oijaodnJoR+6nQ86lEeKpDnamfxoo1HJoxVGZ07ao1MapTW5o1AaZ1cqmCa6ohkKpFW5pLdJpGAal2V6l176pWkapGS6pmF6nvYJp3FanwHapF2apMuJp3kqpub5klWqpTgqp/jppl+poGdakoRqpomqqHranRNapPLJp+K4qGjaqLX5qIcKmYIqoZvKqXTqqSXqop2qozcaqJ9KonYqqqdKqv9PmqWhNqb5aan7Kan0GaOJSasHKpop6qM/Sqma6qd3iqsQOqqsOqOf2aKsKaQqKquzSqxMSgVjxXCBaJwemqmVCamR6qywqgUJJEV0pCt/+qp9aqvtaaWmWgXtUAqAOK27Gq5SGqxXgADlAgDfQDvkdK/4mq/6uq/82q/++q8AG7ABSwXyei9vVy0Vkq5ftq4IWyHdegDf2rA3Eq0SW7EWe7EYm7Eau7Ec27Ee+7EgGwYTQzIoMLKsYApBULBRAFw9gLKQcA4/RQS+sAQWcwrzGgbNGA0o4Ek9wLIqiwM5C4eplXSHQQoTA4xCMLNJYDEk8wDNhLMxlD87+7Q9m3T/P3sD2aIADLsCLFu0IiCvvkALBHAA0XpQrrBiBaBa/VNASGRYZHsKPGVYhmUNYxUscGVAN3AAC3CzI3C2e0uvBiQA5aJz5WINDYAAv1C2AEC4gMuGJFsD2aK0flsAE3NPM+sKjisCCGEywAANSHcyjKtz3ECxBBBDEyO0KBC5wyCvCDEAoNCGAPC2yHQAwGUOCCANCWBAgnRPX0uxX5YQDaC0tou0hUAx9GpYrhBlweJbJcANqTAP/iBCCUANrSVfZOsNCtRa1tA/I2WyFnQDtEBIzhsM/fC3RkQCroAuzwAMCrC8MZu+rlAu9oK1xnAA06st+wC953K5f2svCZQK//cLDQBMtenrs8tiDazlLDzLAvFgv9SAAApgC9myTIvrvl1rLuEQDXqLCggMABCMLntLC7BQAErbDFsrCJtUdeeGDgRQuRTTjKGQCvgyUa01MdMADEqrvfRVvabrF+GLLegwAFJGAPNqAGxoDyzLwsRwxPSqQCUMueYQQzBsWPs7DJI7DO0rD7JQxUtsDurbECpbsPwTQo/LwFEMDCqrc6IQF+dAAMAVC7x7LlnsweWisjcMQwRgC0oLx8ikCMbbtyv8cidgxCZgQSD0xbE7DbWQw3O7w4a1WX6ht3y7xCZQANAAAbTgDhODyHEhyM2iyfZwxUBrDASwD4RMAlwsyv9zfC3nYsSZrC1IbLXzWrDIQMEwkC0jkMbalhSeXL0KEQ9yHCwFq7IQoG2L6FMzm0AVI62D8Mf3cm5SBgwF1byCOwu/hFng8MUE4A56W0H98MXA1Vrz4FqFMUEi4LQTUy5rGIsSnADjbC6x3BDRTAwG8M7O0MTPPMoiEM3pbM1fFkOX68TD8L8OjMGx61v2bA9k/LWzPMvVfMsVpbIWo8fUMM8F1VrWdNCk3ExzPMzu0AALwAB6yL4PMLMZbb/MjMKPW8JCfAplzA+h4MaOBMJti72hkAv2G8ONnArApUO5mwM1azLlEtRju7kKEa3xXA1jpT+Le0+hLND6LAKBRFD/gUsNII1MAZ3PtwC35hK4MYTUmBgK3NDQpXBuL4DLDN0MO/RbS80A2qtJC9CHwZzWCBC4H82GqDCzsbhiffgXtrwLCzwDEdsFV4seSAe7vBDYMeAKmjgFhR2ykB3Zkh0Dj/1pMXsfLx1ci5vSk60FlW0Dir0FzozKVNvZYfDZNRDaRZLZqm3aWwDBcdzDA+C59mXNobC2tYC4UQy4aGsuCYB0+3C21UzLh124yAQsOcANK2a8k6vZ4hCx8tXc02AKjB27f+vaRgDBtCtChuvcJzO9eksKBeTW66vZ+Pu8/QANtjDT5ts/8qq37pBZ23u8ja0C8B27FDO++ksN4iBf/wDgW/qd3qj2te7wxNg9BGE8uA+w0FXswqGQtknXykF8LuIwxA29yVJd05xcAxh+MFM82/xNDWQ8MQQ14U9LyMx74EWQ4NqyALbcytekLiwL4yVA4c1kydksrx3uW+FMtDTQ4S88ZeJg4/0t5E8L39+s4kTA4h780ASA076ltyIOAeTdELbcz2to3tPAzpT83j51vAPQ46j7AiFUdfldzVk+5M00MSENy+r8SzzrDKWt5EDA5P7d1byrLWyoAGGedFdtDESt5UU9MnSMvw+OyBdMA/hiMsYb6Gqey2Xl6FR7unTOBIPd2oxQupW+BNVdipVgDZm96aI+6qRe6qZ+6iConuqqvuqs3uqu/uqwHuuyPuu0Xuu2fuu4nuu6rg0hAAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Ekbom P, Damm P, Feldt-Rasmussen B, et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001; 24:1739.",
"      </li>",
"      <li>",
"       Young EC, Pires ML, Marques LP, et al. Effects of pregnancy on the onset and progression of diabetic nephropathy and of diabetic nephropathy on pregnancy outcomes. Diabetes Metab Syndr 2011; 5:137.",
"      </li>",
"      <li>",
"       Carr DB, Koontz GL, Gardella C, et al. Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery. Am J Hypertens 2006; 19:513.",
"      </li>",
"      <li>",
"       Yogev Y, Chen R, Ben-Haroush A, et al. Maternal overweight and pregnancy outcome in women with Type-1 diabetes mellitus and different degrees of nephropathy. J Matern Fetal Neonatal Med 2010; 23:999.",
"      </li>",
"      <li>",
"       Nielsen LR, Damm P, Mathiesen ER. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 2009; 32:38.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43485=[""].join("\n");
var outline_f42_29_43485=null;
var title_f42_29_43486="Superfic puncuate keratitis";
var content_f42_29_43486=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F60904&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F60904&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Punctate keratitis from toxic chemical",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 338px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chemicals in contact lens solutions may produce toxic or immune reactions on the corneal epithelium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43486=[""].join("\n");
var outline_f42_29_43486=null;
var title_f42_29_43487="HSG showing synechiae";
var content_f42_29_43487=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Hysterosalpingogram showing a filling defect due to synechiae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 306px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Baramki, TA. Hysterosalpingography. Fertil Steril 2005; 83:1595. Copyright &copy; 2005 Elsevier Science, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_29_43487=[""].join("\n");
var outline_f42_29_43487=null;
